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Abstract 
A Study of Partially Liganded Sickle Hemoglobin Polymerization Kinetics 
Donna Yosmanovich 
Frank Ferrone Ph.D. 
 
 
 
Sickle cell anemia is a debilitating disease that results from the polymerization of mutated hemoglobin 
(HbS) inside the red blood cells (RBCs). Polymerization kinetics, including nucleation rates, have been well 
studied for pure HbS, as well as in the presence of nonpolymerizing molecules, such as HbF, or co-
polymerizing molecules such as HbA. For polymerization of HbS in the presence of O2, CO and NO gases 
there is only one study, using CO, but that work did not resolve nucleation rates.  Since polymerization 
occurs in the presence of these gases ins RBCs in the body, this is a significant gap in understanding.   It 
has already been established that there is a relatively small amount of HbS with O2 or CO ligands in gelled 
polymers.  How the presence of these ligands affect the rates of formation of homogeneous and 
heterogeneous nuclei is the focus of this work.  Through the use of a photolysis light scattering technique, 
nucleation rates were measured for HbS solutions partially saturated with CO and then O2.  The 
heterogeneous nucleation rates were found by fitting an exponential function to the scattered light 
growth curves; and the homogeneous nucleation rates were found by analysis of the stochastic variation 
of delay times. The amount of CO saturation was measured through a single wavelength optical density 
measurement, and the O2 saturation was measured through a laser photolyzed spectrum.   This 
experiment obtained the nucleation rates of partially saturated CO HbS from 0% to 60% and partially 
saturated oxygen HbS from 0% to 44%.  It was found that the equilibrium model presented by Sunshine et 
al (J Mol Biol. 1982 158:251-73) is a reasonable approximation for modeling the behavior of nucleation 
and that O2 and CO can be modeled as affecting nucleation rates similarly.  The preceding analysis 
required that the Hb allosteric model be incorporated into nucleation theory, which is also described.  The 
knowledge obtained in this study can help describe polymerization of HbS in vivo, which can lead to 
improved models for describing the time at which RBC sickling occurs during vasculature transit. 
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Chapter 1: Hemoglobin Background 
 
 
1.1.1 Blood and circulation 
Every living cell inside an animal body requires energy to sustain itself.  For humans, 
it is the circulatory system consisting of blood and blood vessels that provide the sustenance 
and means of transportation for the blood to sustain cell life.  Human blood is composed 
primarily of two components, plasma and red blood cells.  Plasma, which is 55% of the total 
volume, is a semitransparent straw colored fluid, which contains dissolved metabolites 
(vitamins, amino acids), wastes, ions and proteins, all necessary for normal cellular function.  
Red blood cells (RBCs), which are about 45% of the volume (this percent is also known as the 
hematocrit, and varies from person to person), aid in oxygen delivery to cells and CO2 
removal.    The other components are leukocytes or white blood cells and platelets which 
together make up less than 1% of the cells in blood.  Leukocytes aid in immunological 
defenses while platelets help clot blood.  Together these are the components of human 
blood.1 
Blood is continuously pumped through the human circulatory system by the heart.  
The heart is a muscular organ which has four main chambers, two on each side which are 
divided by a thick wall of muscle called the septum.  The left and right sides both have an 
upper chamber called the left and right atria and two lower chambers called the left and 
right ventricles.  The right side of the heart pumps the same amount of blood into the lungs 
                                                          
1
 Ross, M. H. (2003).  Histology: A Text and Atlas: With Cell and Molecular Biology. (4, Ed.) Lippincott 
Williams & Wilkins. 
2 
 
that the left side pumps into the rest of the body.  The left ventricle of the heart pumps 
blood first into the arteries, which have strong vascular walls that can handle the high blood 
pressure and velocity of the blood flow coming from the heart. From there, the arteries 
divide into smaller branches, the smallest of which are called arterioles.  They have a strong 
muscular wall that allows them to control the flow of blood into the capillaries by 
contracting completely shut or dilating several times their normal size.  Capillaries have the 
smallest diameter of all the components of circulation.  They can have a diameter smaller 
than that of a single RBC, which means a RBC must squeeze in order to pass through.  
Capillary walls are thin and have minute pores that are permeable to water and small 
molecular substances.  This is necessary for the exchange of fluid, nutrients, electrolytes, 
hormones, etc. between the blood and cells of the body. 
The capillaries are where the blood exchanges nutrients and sustains life for the 
human body.  From the capillaries, blood is collected together into larger and larger vesicles, 
finishing with veins which lead to the right ventricle of the heart.  From there the blood is 
pumped into the lungs, where the RBCs exchange CO2 for O2. After sufficient exchange has 
taken place, the blood recollects and is pumped again by the left side of the heart to the rest 
of the body, repeating the circulatory cycle.2 
 
1.1.2 Red blood cells 
In a cubic millimeter of blood, there are about 5 x106 red blood cells (RBC’s), also 
known as erythrocytes.  In a human being, there are about 25 x1012 RBCs; the most 
                                                          
2
 Guyton, A. C. (2005). Textbook of Medical Physiology: Guyton Physiology. (11 ed.). Saunders. 
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abundant of any single type of cell in the body.  The percentage of RBCs in the blood is 
called the hematocrit.  For men it can be around 42% and for women, 38%.  However, the 
amount can vary greatly depending on the health and activity of the person.    
Healthy RBCs develop in the bone marrow and will circulate for 100-120 days before 
being recycled by the body.  In comparison persons with Sickle Cell disease have RBCs that 
only live for 8-29 days, if the patient is not exercising or under undue stress.3  A RBC will 
spend about 20 seconds in circulation if it goes through the typical cycle of circulation (as 
opposed to storage in the spleen).4 RBC’s are biconcave – donut shaped, with a depression 
in the center that does not reach all the way through.  They are 6-8um in diameter and 2um 
thick.  Their main functionality is to be carriers of the globular protein hemoglobin.  A typical 
human RBC contains about 80- 100 femtoliters of 32 to 36 grams per deciliter of 
hemoglobin.5  It is from the iron in the heme group of hemoglobin that RBCs get their 
distinctive red color. 
 
1.2 Hemoglobin  
1.2.1 Hemoglobin – Historical context 
As early as 1799, Sir Humphrey Davy showed that blood contained more oxygen and 
carbon dioxide than could be dissolved in a solution of pure liquid.6  This led to an increased 
                                                          
3
 McCurdy, P. R., and A. S. Sherman. 1978. Irreversibly sickled cells and red cell survival in sickle cell 
anemia: a study with both DF32P and 51Cr. Am. J. Med. 64:253-258. 
4
 Hogg, J. C. Et. al. (1994) Erthrocyte and polymorphonuclear cell transit time and concentration in the 
human pulmonary capillaries. J. Appl. Physiol. 1795-1800. 
5
 http://www.nlm.nih.gov/medlineplus/ency/article/003648.htm. Accessed March 2011. 
6
 Bunn, H. F. et al. (1986). Hemoglobin Molecular, Genetic and Clinical Aspects.  John Dyson. Saunders Co. 
Chap. 1 p. 2. 
4 
 
interest in studying the relationship between blood and its oxygen content.  Fifty three years 
later in 1862, Felix Hoppe (aka Hoppe-Seyler) studied the relationship between the red 
pigmentation of blood and the binding of oxygen.  He was the first to use the term 
“hemoglobin” and to observe the optical absorption of oxyhemoglobin.7  Felix Hoppe’s work 
would lead George G. Stokes to study spectral changes of hemoglobin by removing the 
oxygen through a chemical reduction with ferrous sulfate.8 This caused the solution to 
develop a purplish color that could be reversed back to red when re-exposed to oxygen.   
This was the first experiment that showed reversible binding of oxygen to hemoglobin.  It 
was also around this time that chemists were able to separate the heme component of 
hemoglobin from the globin.  From this, they demonstrated that the heme could be formed 
into crystals that contained iron and could predict a minimum molecular weight for 
hemoglobin of 16,600 Daltons (very close to today’s accepted value of 16,125 Daltons per 
subunit).  In the 1920’s, Gilbert Adair determined the molecular weight of hemoglobin using 
an osmotic pressure technique, and found it to be around 67,000 daltons.9 This meant that 
hemoglobin was a molecule made up of 4 heme sub groups.   
In 1936, Linus Pauling would publish a paper predicting that oxygen binds to the iron 
in each heme group of the hemoglobin.10  Each hemoglobin molecule can bind up to four 
oxygen ligands.  In the 1960’s, Perutz studied the deoxyhemoglobin and oxyhemoglobin 
crystalline structures and demonstrated exactly how oxygen binding changes the molecules’ 
                                                          
7
 Hoppe, F. (1862). Über das Verhalten des Blutfarbstoffes im Spectrum des Sonnenlichtes. Virchows Arch. 
Path. Anat. Physiol. 23:446. 
8
 Stokes, G. G. (1864). On the reduction and oxidation of the colouring matter of the blood. Proc. R. Soc. 
Lond. 13:355. 
9
 Ada ir, G. S. (1925). A critical study of the direct method of measuring the osmotic pressure of 
hemoglobin. Proc. R Soc. 108A:627. 
10
 Pauling, L. and C.D. Corynell.  (1936). The oxygen equilibrium of hemoglobin and its structural 
interpretation. Proc. Natl. Acad. Sci. 22:210. 
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structure.  The solution of the three dimensional structure of hemoglobin would earn him 
the Nobel Prize in 1962.11 
 
1.2.2 Hemoglobin –as a protein 
A protein is macromolecule that is constructed of different combinations of the 20 
possible amino acid residues.  It has a “backbone” made of mostly Carbon, Nitrogen and 
Hydrogen atoms that are linked together in a linear fashion (figure [1.1]).  The amino acids 
are side chains that project from the main chain and are bound to the backbone Carbons.  
The order of the amino acid residues in a protein is referred to as the primary structure.  The 
primary structure’s sequence of amino acids is usually stabilized by hydrogen bonds12 into 
another more complex structure, such as an alpha helix or beta sheet which is then 
connected by short non-helical segments referred to as random coils or turns (secondary 
structure, figure [1.2]).  Alpha helices are represented by helical ribbons, beta sheets by 
arrows, and random coils by a thickened line.  Alpha helices are stabilized by hydrogen 
bonds between the C=O and fourth down H-N groups of the protein backbone.13  The 
tertiary structure is the arrangement of the secondary structure pieces into the overall 
shape of the protein molecule (figure [1.2] middle).  This is the folded protein and can be 
stabilized by non-local interactions such as a hydrophobic core and a hydrophilic exposed 
surface (as is the case in hemoglobin). Quaternary structure is several separate tertiary 
protein molecules put together.  They then behave or function as a single protein complex 
                                                          
11
 http://nobelprize.org/nobel_prizes/chemistry/laureates/1962/perutz-bio.html. Accessed April 2011. 
12
 IUPAC-IUB Commission on Biochemical Nomenclature (1970). Abbreviations and symbols for the 
description of the conformation of polypeptide chains. Journal of Biological Chemistry 245: 6489–6497. 
13
 Finelstein. A. V. and O. B. Ptitsyn. (2002). Protein physics: A course of Lectures. Academic Press.75-76 
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and are stabilized by: hydrophobic interactions, salt bridges, hydrogen bonds and disulfide 
bonds (figure [1.2] right). 
Normal adult Hemoglobin (HbA) is a symmetrical quaternary molecule made up of 
four subunit tertiary protein molecules.  The subunits are designated α1, β1, α2 and 
β2.  These names are not to be confused with the secondary protein structure names of α 
helix and β sheet.  The subunits, α1,2 and β1,2 are very similar in their secondary 
structure.  They are each made up of α helices and random coils which connect the helices, 
as well as a heme group.  However, their slight differences start at the primary structure 
level, where α subunits have linear sequence of 141 amino acids; β has 146.  
  
 
 
 
Figure [1.1]: Protein backbone. “R” is where amino acid residues would be.14 
 
 
 
 
                                                          
14
 Bunn, H. F. et al. (1986). Hemoglobin Molecular, Genetic and Clinical Aspects.  John Dyson. Saunders Co. 
p. 13. 
7 
 
 
 
Figure [1.2]: From PDB (Protein DataBase). Left: hemoglobin alpha helix (the secondary 
structure). Middle: alpha 1 subunit (tertiary). Right: hemoglobin quaternary structure. 
 
 
 
Each subunit of Hb, α1,2 and β1,2, has designations given to their multiple alpha 
helices in order from A to H.  The additional amino acid residues in β1,2 are found mostly in 
an extra D helix which is not present in α1,2. The heme group found in each subunit is 
ferroprotoporphyrin IX; the molecular structure is shown in figure [3]. The Heme is inserted 
in a gap between the E and F alpha helices of each subunit.   The iron is covalently bonded 
to the Nitrogen of the proximal F8 Histidine, which is the eight amino acid on the F helix.  
The heme is stabilized by a large number of interatomic contacts, about 35 between various 
residues in the F helix and roughly 28 in the E helix.  When the iron atom does not have 
oxygen bound, it has unpaired electron, as well as a stressed bond and the proximal 
Histidine of the F-Helix.  In oxygenated Hb, the iron atom is able to pair its electrons, 
thereby having a lower spin state and decreased magnetic moment.   
It is important to note that a ligand is by definition an ion or a molecule that binds 
to a central metal atom and donates or shares one or more of its electron pairs.  Here the 
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Nitric Oxide (NO), Carbon Monoxide (CO) and Oxygen (O2) will be commonly referred to as 
ligands which bind to the iron atom in the heme in hemoglobin.  
 
 
 
 
Figure [1.3]: The molecular structure of the Hb heme group, ferroprotoporphyrin IX15 
 
 
 
The hemoglobin quaternary structure can separate into two “dimers” or two halves 
each with the subunits of: α1β1 or α2β2. The four subunits of hemoglobin interact via weak 
non-covalent bonds and hydrogen bonds.  The contacts within each dimer are the same for 
oxygenation and deoxygenation.  However, the α1β2 contact loses 18 molecular contacts and 
7 hydrogen bonds when Hb enters the oxygenated, or relaxed state.  The reduction in 
contacts allows oxyhemoglobin to dissociate reversible into α1β1 dimers, at a rate of 10
6 
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more than in deoxyhemoglobin.16   This dimerization happens to an even greater extent 
when Hb is in dilute solutions.   
 
1.2.3 Hemoglobin –the allosteric model 
Liganded Hb has a different quaternary structure from unliganded Hb.  Unliganded 
Hb favors a structural configuration called a Tense or T-state.  When Hb is in this state it 
binds oxygen at a lower rate, in comparison to its other configuration, the Relaxed or R-
state. The Hb molecule undergoes changes in both the quaternary and tertiary structure 
when switching between the R and T states.  In the quaternary structure, the R-state will 
cause the two αβ dimers to rotate 15° in relation to each other.  Also, the two β subunits 
will separate by 7.5° as shown in figure [1.5] below.17  The tertiary structure will have 
changes in the area of the heme group.  When deoxygenated, the iron atom will displace 
slightly out of the porphyrin ring, causing the decreased oxygen affinity of the T-state.  
When Hb is in the R-state the iron atom will lie in the plane of the porphyrin ring allowing 
for a better contact with the proximal histidine as well as allowing stronger binding between 
the iron atoms and ligands such as oxygen.18 
The R and T-states are quaternary states.  This means that the affinity for a ligand 
depends on the quaternary structure, not the number of ligands already bound.  Therefore, 
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 Bunn, H. F. et al. (1986). Hemoglobin Molecular, Genetic and Clinical Aspects.  John Dyson. Saunders Co. 
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p. 33-34. 
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one of the four subunits of the Hb molecule cannot be in the R-state while the others are in 
T.   This is a well tested theory19  whose model is described by Monod, Wyman and 
Changeux in 1965 (the MWC model).  Pictorially, the model is shown in figure [1.4].  This 
model allows hemoglobin binding to be described by just three variables, L, kR and c.  L is the 
ratio of the initial population of T-state Hb to R-state Hb: 
  [ ] [ ]                   (1.1) 
 
 
And c is the ratio of heme ligand affinities for the two states: 
                           (1.2) 
 
Where K is the dissociation equilibrium constant: 
     
→        (1.3) 
 
 
 
 
Figure [1.4]: The MWC model. 
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 Shulman, R.G.,  J. J. Hopfield. S. Ogawa. (1975). Allosteric Interpretation of Hemoglobin Properties.  
Quarterly Review of Biophysics.  8:325-420. 
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Hemoglobin is often described as having a “switch over point.”  This is the point at 
which it is energetically favorable to be in the R-state over the T-state.  This occurs at 
around the binding of the third ligand, or rather, 2.7 ligands.  See figure [1.5] for the energy 
level diagram.  The figure shows that the energy level of T0, the unliganded T-state Hb 
molecule, has a lower energy than R0.  Therefore Hb, without ligands will prefer the lower 
energy state and will most likely be found in T0.  At around 3 ligands, the energy levels are 
almost the same, and Hb can now “switch” in the R-state conformation.  This is the switch 
point, which allows the molecule to remain in the lower energy configuration while still 
binding ligands20.  This model uses the parameters of   ,  , and  .  However, here    is 
the ratio of T0 to    (the initial populations of each unliganded state) and defines the R 
enery levels in respect to the T ones.   and   are the separation between the energy 
levels in the R and T-states respectively.  Here the parameter c is defined as above, but now 
we also have the relation below for each population ratio   : 
   
  
  
    
 
   (1.4) 
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 Shulman, R.G.,  J. J. Hopfield. S. Ogawa. (1975). Allosteric Interpretation of Hemoglobin Properties.  
Quarterly Review of Biophysics.  8:325-420, p. 5. 
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Figure [1.5]: Left: The R and T state quaternary structure.21 Right: Energy level diagram. 
 
 
 
When the fractional saturation of Hb is plotted versus oxygen pressure, a curve with 
a sigmodial shape will be obtained (figure [1.5] below).  The sigmodial shape indicates that 
Hb binding is a cooperative process, i.e. as Hb switches to the R-state it binds ligands at a 
faster rate than in the T-state.  The fractional saturation of Hb is defined as: 
  
[  (  ) ]
[  ] [  (  ) ]
   (1.5) 
 
This is the ratio of Hb with Oxygen bound to the total amount of hemoglobin (both 
liganded and unliganded).  The Hill coefficient is a way to characterize the cooperatively of a 
molecule.  Below is the Hill equation, with n being the Hill coefficient.   If the slope for n is 1, 
then the system binds ligands only at a single rate.  Hb has a Hill coefficient between 2.8 and 
3.0 which means it has positively cooperative binding. The equation for n is given below: 
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      (
   
   
)  (1.6) 
 
Where     is the pressure at which the Hb solution is 50% saturated with ligands.  In 
figure [1.6] below the Hill coefficient for Hb has a slope of 1 near the beginning and end of 
the binding curve, with a maximum slope of 3 in the middle.  That is due to most of the Hb 
molecules being in the T-state in the beginning of the process, and in the R-state in the end 
of the process. 
 
 
 
 
Figure [1.6]: Left: The oxygen binding curve.  Right: The Hill coefficient plotted. 
 
 
1.2.4 Other types of Human Hemoglobin – Fetal Hemoglobin 
Until now, when Hb has been mentioned, it was assumed that the species of Hb was 
HbA: normal adult hemoglobin.  There are however, many species of Hb, some naturally 
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occurring in humans, as well as some abnormal variants.  The Hb species most pertinent to 
this thesis are: HbA (Normal Adult Hemoglobin), HbF (Fetal Hemoglobin) and HbS (Sickle 
Hemoglobin).  Hb will now refer to Hemoglobin in general and not any one particular type. 
Fetal Hemoglobin is just one example of a naturally occurring variant of Hb.  It is the 
main mechanism of oxygen transport in the last seven months of human fetal development.  
HbF has a higher oxygen affinity in comparison to HbA.  Whereas HbA has a p50 at an O2 
pressure of 26.8 mmHg, HbF is half saturated at just 19 mmHg.  This higher affinity allows 
the fetus to recover oxygen from the mother’s blood stream in order to sustain itself.  After 
birth the amount of HbF rapidly decreases from around 80 ±10 % to less than 10% after 6-12 
months due to the increased synthesis of HbA.  Normal adults have varying amounts of HbF 
in their RBC’s but the amount is usually less than 2%.  HbF levels can be elevated in adults in 
circumstances of pregnancy and congenital disorders such as hereditary persistence of HbF. 
The structural difference between HbA and HbF is in the β subunits of the 
quaternary molecule.  HbF differs in 39 of the 146 amino acid residues, enough of a 
difference to allow this subunit to be named γ in HbF.  Four substitutions which occur at the 
     interface are believed to cause the molecule to be more stable and decrease its 
dissociation into monomers in comparison to HbA.  HbF also interacts less with allosteric 
effectors, small molecules that change the “switch over point” of Hb.  One common 
allosteric effector, 2,3-DPG binds to the deoxy form of HbA in the cavity made by the four 
subunits in the middle dyad axis.  By binding to the deoxy structure, it stabilizes the T-
structure, and therefore makes the switch into R-state more difficult.  However, once the R-
state is achieved, 2,3-DPG is ejected due to loss of contacts.  2,3-DPG shifts the oxygen 
binding curve to the right, thereby requiring a higher oxygen pressure to achieve the same 
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number of ligands bound in a Hb system.  In HbF one of the contacts for the 2,3-DPG binding 
site is mutated; β 143 Histidine becomes γ 143 Serine thereby dimishing the effectiveness of 
2,3-DPG.22  HbF like HbA can dimerize and reform into quaternary structures.  If HbF is 
mixed with HbA, the dimers can reform into a mixed species; HbAF with subunits of: 
        . 
 
1.3 Sickle Hemoglobin 
1.3.1 Sickle Hemoglobin – Historical Background 
Sickle Hemoglobin (HbS) is another variant of Hb which is caused by inheriting two 
homozygous sickle genes.  It is so named from the sickle shaped RBCs found in those with 
Sickle Cell Anemia (see figure [1.7]).  In humans, there are two genes needed in order to 
make each of the subunit types of Hb, i.e. two genes for α, β, γ, etc.  Children inherit one 
gene for each type from each parent.  Since these genes are co-dominant, both will be 
expressed.  For example, if a person had inherited one normal and one sickle gene, they 
would express both sickle and normal β groups in their Hb; a condition called “sickle trait.” 
They also would have a 50/50 chance of passing on the sickle gene to each of their children.  
See figure [1.7] below. 
 
 
                                                          
22 Bunn, H. F. et al. (1986). Hemoglobin Molecular, Genetic and Clinical Aspects.  John Dyson. Saunders Co. 
p. 70. 
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Figures [1.7]: Left: Sickle shaped red blood cell. Middle: Inheritance of sickle and normal 
genes from parents with sickle trait.  Right: Prevalence of Malaria and the sickle-cell 
gene in Africa. 
 
 
 
The Sickle mutation was found generally in African populations where there was a 
historical prevalence of malaria (see figure [1.7]).  It has been found that HbS has some 
protection against Plasmodium falciparum, the most severe form of malaria.  P. falciparum 
is also the most common type of malaria, causing 80% of infections and 90% of malaria 
associated deaths.23  However, studies have shown that the protection offered by sickle cell 
trait is mostly beneficial to infants and those less than 60 weeks old.2425  Surviving older 
children and adults without HbS have usually developed immunity to malaria, so there is no 
observable difference in their susceptibility later in life in comparison to those with the 
sickle trait.  The malarial infection begins in the liver, where it multiples.  Following the 
rupture of its host cells, malaria will then spread to the blood and infect RBCs.  Circulating 
infected RBCs will be destroyed by the spleen.  However malaria circumvents the spleen by 
                                                          
23
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displaying adhesive proteins on the surface of infected RBCs which will cause the cell to 
become lodged in small blood vessels.  This allows the parasite to be sequestered from 
circulation to the spleen as well as causing hemorrhagic complications.26  The exact 
mechanism of how HbAS protects against malaria infection has not been well established.  
One theory is that the malaria infected RBCs with HbAS will deform and sickle when the 
virus consumes oxygen and will therefore be removed from circulation before the cell 
becomes adherent and can multiply elsewhere.27  Another theory is that the virus crowds 
the cell as well as lowering the pH, thereby enhancing sickling of the cells. 
Malaria has been a major cause of death of children worldwide and is also the 
strongest force for selective evolutionary science worldwide.28   There is growing evidence 
of many diverse genetic adaptations to malaria, including the sickle gene. The distribution of 
the Sickle gene globally has mostly been due to emigration.  However, through tracking 
phenotypes of the Sickle gene, it was found that the mutation has risen independently in 
West Africa from Central and East Africa.   
Sickle Cell Anemia was recognized as a disease in Africa for centuries before its 
clinical manifestation would be recognized by western science.29  It was already known by 
local populace that it ran in families and had differing levels of severity.  Most cases of 
homozygous HbS in Africa did not live past infancy due to the combination of malnutrition, 
prevalent infections and lack of medical care.  This led to a mistaken perception that the 
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disease was relatively uncommon in Africa, but prevalent in countries like the United States.  
James B. Herrick, an American physician would be the first to describe a case of sickle cell 
anemia in medical literature in 1910.   His patient suffered from breathlessness, palpitations 
and jaundice.  A medical examination also found he had an enlarged heart and anemia.  Dr. 
Herrick would be the first to show a photomicrograph in his report of the thin crescent 
shaped red blood cells.30  In 1915, Victor Emmel, an anatomist would show that the sealed 
blood of a sickle patient between a microscope slide and a cover slip would sickle over 
time.31  Likewise, the patient’s father’s blood would sickle, even though he was 
asymptomatic.  This would be the beginning of understanding the inheritance of the disease 
as well as sickle trait. 
In 1927 a surgeon, Vernon Hahn and an intern, Elizabeth Gillespie, found that they 
could sickle the RBCs in a suspended drop when the oxygen pressure was below 45 mmHg.  
They also showed that sickling was reversible by reoxygenation and that cells without Hb 
would not sickle.  In 1940, Irving Sherman, a student at Johns Hopkins would find that at 
reduced oxygen tensions the RBCs of those with anemic symptoms would sickle quicker 
than those with asymptomatic sickle trait.  He also found that when the deoxygenated sickle 
cells were viewed under a polarized microscope they exhibited birefringence.  This meant 
that certain molecules of the cell become oriented when they undergo sickling.32  Hb was 
identified as the cause of the RBC sickling by Janet Watson, a hematologist from Brooklyn in 
1948.  She would note that sickling did not become significant until the HbF in an infant was 
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replaced by mostly “adult” hemoglobin.  Finally in 1949, Linus Pauling would use boundary 
electrophoresis to show that the Hb from those with sickle cell anemia had a different 
mobility than the Hb from a normal individual.  Likewise, those with sickle trait had about 
equal amounts of normal and sickle type Hb.  This would be the first identification of a 
molecular disease and its inheritance.33 
 
1.3.2 Sickle hemoglobin – as a protein (from mutation to polymerization) 
Sickle hemoglobin is a disease caused by a mutation in the βs gene.  This mutation 
produces an amino acid substitution in the 6th position of the β subunit of Hb: β 6 Glu → Val.  
The negatively charged glutamic acid is replaced by hydrophobic valine, see figure 8 below 
for the amino acids’ molecular structure.  This single amino acid substitution in the β 
subunits causes HbS to polymerize when deoxygenated.  The polymerization must be a 
consequence of the substitution, which is an alteration to the surface of the molecule.  
Aside from the polymerization, HbS functions the same as HbA.  For example, if the p50 
oxygen binding curve was compared for the two hemoglobins, they would be the same, as 
long as the HbS was dilute.34  Otherwise if the concentration of HbS was above solubility, it 
would start to form polymers when deoxygenated and the binding curve would not be 
correctly measured. This is because the binding of ligands to HbS in a polymer is weaker 
than HbS in solution. 
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Hydrophobic bonding and electrostatic interactions are the primary forces behind 
the formation of the polymers.35  When a polymer is formed, it contains 14 strands, or 
rather 7 double strands of monomers with a right handed helical twist (figure [1.8] ).36  This 
configuration of the sickle fiber was determined by electron micrographs. However, it does 
not give any information about the orientation of the HbS molecule in the fiber structure.  
Using other techniques such as x-ray structural information and optical data, researchers 
were able to constrain the X axis of the molecule to be within 22 degrees of the fiber axis.37 
38  Although this constrains the molecules position, it does not provide definitive information 
on the intermolecular contacts between molecules in the fiber. 
There is however better information about possible molecular contacts from HbS 
crystals.  Nevertheless, the crystals are packed differently: they are arranged in pairs of 
parallel double strands, with each strand staggered by a half molecule and rotated by a half 
turn.  There are two contacts that were identified in the crystal structure, axial and lateral.  
Axial are contacts between a molecule in a strand and the molecule directly vertical above 
or below it in the strand.  Lateral are the contacts between the molecules from side to side.  
In figure [1.9], lateral contacts are made between the β 6 of one HbS to the β 85 and β 88 of 
another molecule.  Notice how only one subunits’ β 6 mutated contact is needed to make 
this structure.  There is also a lateral contact between β 73 and β 4 on the other Hb 
molecule.  As for axial, there are several, one is the β 22 with the α 20 above it.  Axial 
contacts can include both α and β subunits as seen in figure [1.8]. 
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Figure [1.8]: The possible axial and lateral contacts of the Hb crystal 
 
 
 
The packing of HbS molecules in the crystal is structurally different than the fiber.  
The fiber is better described by a group of 7 double strands which are packed and twisted, in 
comparison to a lattice of parallel and anti-parallel double strands.  It is generally accepted 
that the contacts used to make a crystal can be used in the fiber formation.  However, 
because the fiber structure cannot be studied like a crystal structure, what contacts exist in 
the fiber cannot be definitively known. 
22 
 
 
Figure [1.9]: Right: Glu & Val amino acids. Left: 14 strand polymer with twist. 
 
 
 
The HbS polymer is formed through a double nucleation pathway.  Deoxygenated 
HbS molecules form nuclei in solution, coming together and separating at random.  
Eventually, enough molecules will nucleate to overcome the energy barrier, and the growth 
process will become energetically favorable.  The formation of a nucleus is a stochastic 
event and the critical nucleus is the size of the nucleus at which the addition of a monomer 
becomes favorable.  The nucleus will grow into a polymer.  However, HbS can also form new 
nuclei on preexisting polymers, which will also grow into new polymers.  The single 
nucleation event is called homogeneous nucleation, and is defined by   , the homogeneous 
nucleation rate.  The growth of nuclei on existing polymers is called heterogeneous 
nucleation and is referred to as the heterogeneous nucleation rate,  .  See the figure [1.10] 
below for clarification of the double nucleation model.  Due to the two pathways of 
nucleation, HbS polymer growth is exponential. 
 
23 
 
 
Figure [1.10]: The two pathways of nucleation 
 
 
 
1.3.3 Sickle hemoglobin –hybrid and partially liganded molecules 
There were many studies done on sickle polymer formation to ascertain the 
contacts necessary.  Most of the early experiments were done using Hb mutants, molecules 
that have different amino acids at key locations in the α and β subunits.  These experiments 
were often conducted using a gelation and solubility measuring technique.  Gelation, or 
rather minimum concentration required for gelation (MGC) is done by evaporating the HbS 
solution with a dry gas until it no longer will flow due to fiber formation.  Such a technique 
was used by Singer and Singer to establish that HBSF (fetal and sickle hemoglobin hybrids) 
will not enter a polymer.39  Meanwhile, HbS/HbA and HbS/HbC hybrids will enter a polymer.  
This proved that only one β6 contact was required to form a polymer, and that the HbF 
molecule was just too different to enter a polymer even as a hybrid.  Solubility 
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measurements are done by centrifuging a concentrated solution of deoxygenated Hb.  The 
polymers will separate from the solution and the concentration of the supernatant can be 
measured for the solubility40.  Aside from providing a more precise measurement than 
gelation, this technique also gives information on other properties such as solvent 
conditions and ligand binding. 
Other forms of Hb can polymerize, one such example is methemoglobin, the ferrous 
form (Fe+3) of Hb.  At low pH and with organic phosphates it can assume a T-state structure.  
If concentrated, met-HbS will still polymerize.41  It is also possible to have Nitric Oxide (NO) 
bound to HbS in the T-state and still create a polymerized gel.42  Likewise, an experiment 
was done that showed oxygenated Hb can be partially converted to a T-state and formed 
into a gel.43  Likewise, solubility measurements done by Hofrichter and Eaton showed that 
polymerized HbS had small amounts of oxygen bound to the monomers in the polymer.44 45  
Similar results were found using Carbon Monoxide (CO).46 47 48  Although it is known that O2 
and CO can enter gelled HbS, it is not known how the presence of these gases effect 
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polymer growth in vivo or in vitro.  
 
1.3.4 Sickle Hemoglobin – as a disease  
Sickle cell anemia affects 70,000 to 100,000 African Americans.49  People who are 
homozygote for sickle cell disease will have a decreased lifespan of 42 years for men and 48 
years for women.50  Newborns with the disease will begin to exhibit symptoms around the 
5th month of new born life.  That is when the baby’s fetal Hb is mostly replaced with HbS.  
The first infant symptom of Sickle Cell Anemia is hand-foot syndrome (dactylitis).  Sickled 
cells become stuck in the small blood vessels in the extremities such as the hands and feet, 
blocking the flow of blood and causing swelling (figure [1.11]).  Another ubiquitous 
complication is chronic hemolytic anemia.  Anemia is a condition caused by not having 
enough healthy RBC’s to deliver oxygen to the body. Since the RBC’s of Sickle homozygotes 
only survive for about 15 days rather than the usual 100, they suffer from chronic anemia.  
Anemia side effects include tiredness, irritability, shortness of breath, slow growth, jaundice 
and delayed puberty.  Hemolytic anemia is a type of anemia associated with the abnormal 
breakdown of RBCs in the blood vessels or elsewhere in the body leading to free Hb in the 
plasma.  The side effects of this condition are similar to normal anemia, but also include an 
enlarged spleen which may require a splenectomy.  The most substantially painful symptom 
of sickle cell disease is the sickle cell crisis.  It is believed to be caused by sickled cells 
restricting oxygen delivery to many tissues in the body, and is accompanied by episodes of 
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great pain that can last for weeks.  There is no effective treatment for a crisis once it 
happens.  Pain medications and the breathing in of oxygen from a mask are the only current 
therapies available; neither of which address the issue of providing needed oxygen to 
tissues cut off from the normal blood flow. 
Other side effects of sickle cell disease include chronic lung disease, pulmonary 
hypertension, avascular necrosis, kidney failure, retinopathy, leg ulcers, cerebral infarctions, 
stroke and morbidity.  Chronic lung disease is term that describes the symptoms of difficulty 
breathing, chest pain and exercise intolerance.  It can be caused by sickled cells restricting 
the oxygen supply to lung tissue and causing it to die.  Pulmonary hypertension is caused by 
the abnormal blood flow in sickle cell patients.  They develop high blood pressure in the 
arteries that supply blood to the lungs which leads to fatigue, dizziness and shortness of 
breath.  Avascular necrosis is the death of bone tissue due to lack of blood supply usually 
occurring in the hip joint.  It can cause extreme pain and flattening or collapsing of the bone, 
see figure [1.11] for an MRI scan of avascular necrosis.  Kidney failure can also occur from 
chronic sickling and reduced blood supply to the kidneys.  Likewise, if the nerve tissue in the 
retina does not receive enough oxygen it can weaken and the person can become vision 
impaired or blind, a condition called retinopathy.  Leg ulcers are one symptom whose 
pathology is not yet defined.  They occur around 20-50 years of age and begin as small 
protruding crusting sores on the legs (figure [1.11]).  Occurring more often in males than 
females, they can appear for a short while or persist for years, they can heal and reoccur.  
The only treatments available are blood transfusions and hyperbolic oxygenation (to try to 
get oxygen to the local blood vessels near the sore). 
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Sickle cell disease is the most common cause for stroke in children.51  Strokes are 
also more common in children than adults with the average victim being around 6 years 
old.52 53  Around 11% of sickle cell patients will experience a clinical stroke syndrome by age 
20.54  It usually occurs by occluding the middle cerebral and internal carotid arteries.55  A 
substantial study conducted on 130 children with sickle cell anemia, STOP, The Stroke 
Prevention Trial, found that routine blood transfusions that kept the amount of HbS around 
30% decreased incidence of stroke by 90%.  The trial was so successful it was terminated 
early.  However, cerebral infarctions (a stroke where blood does not reach brain tissue 
thereby causing it to die, with varying degrees of severity) were still taking place.56  Another 
study of 185 patients found that at a mean age of 10 years, 44% of children had an overall 
prevalence of infarction or related ischemia.57  Children also suffer from silent infarctions, 
meaning they do not know they are occurring, but upon detailed examination cognitive 
impairment and other subtle neurologic affects will be found.58  Another study of 27 
randomly selected children who are not clinically affected by strokes, found 33% with mild 
retardation levels, which is compared to a normal 1.45% for inner city black children.59   This 
demonstrates that even though the patients do not suffer from overt stokes, they still have 
chronic hypoxia in their brain. 
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Figure [1.11]: Right: swollen hands from Sickle Cell Dactylitis. Middle: vascular necrosis 
of the hip joint. Right: leg ulcer. 
 
 
 
 
1.3.5 Sickle hemoglobin – therapies 
 The only known cure for sickle cell anemia is a bone marrow transplant.  However 
with the risk of death (5-10%) and the unlikelihood of finding a matching donor, this is an 
option available to very few with the disease. Human leukocyte-associated antigens, or HLA 
is a type of bone marrow transplant used to cure those with cell disease.  In a study of 22 
patients under the age of 16 who received HLA transplants between 1991 and 1995, 20 
survived.  The two that died had a central nervous system hemorrhage or graft-versus host 
disease (GVHD) which sometimes develops when white blood cells from the donor of the 
graft identify cells in the patient’s body (the host) as foreign and attack them.   In four 
patients the graft was rejected and in 3 of those 4 sickle disease reoccurred.  Sixteen of the 
patients had a stable engraftment and 1 of the 16 had stable mixed chimerism (meaning 
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stable amounts of HbS/HbA or HbA after the transplant).60  A study done in 2001 on 59 
children ages 3.3 to 15.9 tracked the results of their bone marrow transplants from HLA 
identical sibling marrow allografts.  The higher the number of matching HLA antigens, the 
greater the chance that the patient’s body will accept the donor stem cells.  Fifty five 
patients survived the procedure and 50 survived free from sickle cell disease.  Thirteen 
patients had stable mixed donor host hematopoietic chimerism; meaning they had stable 
amounts of HbS/HbA red blood cells being produced based on whether their donor had 
sickle trait or just HbA.61  Although bone marrow transplant can cure Sickle Cell disease, 
there remain some limiting factors.  First, an identical HLA donor must be found to ensure 
the highest probability of success.  For many with SCD there may not be an acceptable 
donor.  Second, to also ensure a higher probability of healthy recovery following grafting, 
the patient must have vital organs which have not been too greatly damaged from SCD.  
Finally, even with the above criteria, there is still a 5-10% risk of death, and also a risk that 
the graft will be rejected.  Not many with SCD can or are willing to risk a bone marrow 
transplant. 
 Routine blood transfusions are another common therapy for SCD.  There are three 
main types of transfusions, simple transfusion, partial exchange and chronic exchange.  
Simple transfusion is best for those who are severely anemic because it increases the 
amount of HbA RBC’s without removing any blood from the patient.  An exchange 
transfusion is best for removing HbS RBCs from the patient.  Usually exchange transfusions 
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are used for those with acute cerebrovascular accidents, multiorgan failure syndrome, acute 
chest syndrome (or other lung disease) and before surgery or anesthesia.  Chronic 
transfusions are transfusion programs that will aim to keep the percentage of HbA in the 
patient above 50 to 70% which means an exchange every 3 to 4 weeks.  Usually this therapy 
will be used for children who had cerebral vascular occlusions, stroke or those with chronic 
congestive heart failure.  Transfusions have been used to try to treat other symptoms of the 
disease such as frequent crisis events, deterioration of health when all other treatments 
have been unsuccessful, adults with cerebrovascular accidents, leg ulcers and chronic organ 
failure.  However, it has not been shown that transfusions remedied any of those symptoms.  
If chronic transfusions are used to treat these symptoms, the patient will usually have a 
relapse or exacerbation of symptoms once treatment is stopped especially if treatment is 
suddenly terminated.   Sickle patients will still have the same complications as anyone 
undergoing transfusions.  This includes volume overload, which is when too much blood has 
been transfused too quickly.  This can cause congestive heart failure and pulmonary edema.  
They are also at risk for iron overload (whose treatment also carries side effects) and 
alloimmunization to red blood cell antigens, making compatible blood difficult to obtain as 
well as increasing the probability of having a life threatening allergic reaction to the 
transfused blood.62  They are also at risk for contracting Hepatitis B and C, as well as at risk 
for contracting HIV if receiving transfusions in a country that does not thoroughly screen 
their donated blood for HIV antigens.63 
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 Hydroxyurea (HU) is a daily dose prescription drug used to treat those with SCD.  
Originally it was used to treat cancer, but is beneficial for sickle patients because it increases 
the amount of HbF produced by the body.  HU increases the count of F-cells (cells with only 
HbF) and the overall percent of HbF in other erythrocytes.  Since there is a higher amount of 
non-polymerizing Hb species, patients see improvements in several symptoms such as 
frequency of crisis episodes and acute chest syndrome.  They will also need fewer blood 
transfusions and will have less hospital visits.  A study reported in 2003 also found that 
children on regular long term HU treatment had growth rates comparable to normal 
children, whereas untreated children with SCD have below average growth.64 Nevertheless 
the efficacy of this drug varies for each person taking it. In a study completed in 1996, 150 
patients were tracked for their response to HU for 2 years. Half the patients had long-term 
increments in HbF, with the top two quartiles seeing an increase of 18.1% and 8.8%.  The 
lower two quartiles changed little from baseline, having 4.2% and 3.9% HbF.  Only the top 
three quartiles saw a substantial increase in F cells which persisted for two years, with the 
lowest quartile returning to baseline level after the first year.65  The effectiveness of this 
drug also depends on the patient taking it daily in the prescribed regime. HU also has some 
side effects, which are alleviated once treatment is stopped, such as bone marrow 
suppression and mild neutopenia; i.e. decreased white cell count. 
 Pain medications are another important treatment for SCD.  The pain associated 
with sickle cell can be intense and last for many days as in a crisis, or mild but still enough to 
interfere with everyday functionality.  Severe pain is treated with either prescription pain 
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killers such as naproxen, codeine and morphine, while more mild pain can be treated with 
acetaminophen or ibuprofen.  Other common treatments for SCD include: breathing in of 
supplemental oxygen for low oxygen levels as well as receiving fluids through an IV to 
reduced blockage of vessels.  It is also important for sickle patients to receive antibiotics 
when they get an infection especially pneumonia or acute chest syndrome, since these 
complications can lead to morbidity.66  There are other experimental treatments for SCD 
whose efficacy has not been studied.  This includes gene therapy (turning off the sickle 
gene) as well as drugs which work similarly to HU such as Butyric acid and Decitabine (which 
may have less side effects).  Finally, Nitric oxide (NO) is also an experimental treatment 
which has been found to dilate blood vessels, reduce the stickiness of RBCs, reduce sickling 
of HbS, but inhalation of NO does not aid in alleviating a crisis once it has already begun.67 
 Although several treatments described here are proven to help prevent 
complications and improve the patient’s condition, the median survival age for those with 
SCD remains in the early 40’s.  In a massive study done on 3764 patients with SCD, 18% of 
deaths were due to overt organ failure (mostly renal) and 33% due to acute sickle crisis 
(with 78% of those having pain or acute chest syndrome and the rest having had a stroke).  
Early mortality was highest in patients who were symptomatic, and life expectancy could be 
improved if there is a high level of HbF.68  Clearly, there is still a great need for better 
treatments with less side effects especially for those who are unresponsive to the current 
therapies or unable to maintain a strict regimen of transfusions or medication. 
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1.3.6 Sickle hemoglobin – trait 
About 300 million individuals worldwide have sickle cell trait (SCT).  If they are 
expressing the normal Hb α genes, they will have about 42% HbS in their blood as opposed 
to those with α gene deletions who have 29% HbS. 69  HbS heterozygotes are generally held 
to be asymptomatic in the medical community.  However, it is important to note that much 
of the information on sickle trait complications is anecdotal and not part of a rigorous 
scientific study.  There are some side effects that are generally accepted to be present in 
those with SCT, namely, anatomic and functional differences in the cerebral vasculature, 
urine concentrating ability, and red cell rigidity.70  However none of these symptoms are life 
threatening.  There are other more serious complications that have been shown to occur 
with a slightly higher frequency in those with SCT when compared to the general 
population.  Those are renal medullary cancer, hematuria, renal papillary necrosis, 
hyposthenuria, splenic infarction, exertional rhabdomyolysis and exercise related sudden 
death.   
Renal medullary carcinoma is an aggressive tumor of the kidney observed almost 
exclusively in young individuals with SCT.  After diagnosis the medium survival is about 15 
weeks.  Hematuria, blood in the urine, was found to occur in 4% of SCT males admitted to a 
Veterans Administration hospital, compared to 2% for African American males with normal 
Hb.  It can range from mild to severe and could be caused by polymerization in the long vasa 
recta of the renal medulla.  Hyposthenuria is the loss of the kidney to concentrate urine and 
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may be related to microinfarctions in the renal medulla.  Splenic infarcts are rather 
uncommon and have been mostly seen to occur in males with over 40% HbS who were in a 
low oxygen environment.  Finally, rhabdomyolysis is the breakdown of muscle fibers and the 
release of the fiber contents (like myoglobin) into the blood stream.  This usually occurs 
from exercise, lack of oxygen supply, hypothermia, dehydration, overheating, exertion at 
high altitudes and exertion in non-conditioned individuals. 71 
Rhabdomyolysis is often found as the cause of death in cases of sudden morbidity in 
those with SCT.  A case report of 16 SCT related deaths found that although the 
circumstances varied greatly, there were several triggers in common: mild to moderate 
exertion, dehydration and hyperthermia.  Several of the people were physically exerting 
themselves when they suddenly felt lethargic or pain.  Post mortem examination revealed 
rhabdomyolysis and/or micro occlusion as the cause of death.  It is believed that cells 
sickling in the muscles could be the start of these complications by changing the pH of the 
body.  The time from the onset of symptoms to morbidity varied greatly from 20 minutes to 
2 weeks in one case.  The most precise information on rhabdomyolysis related deaths 
comes from US Army recruit data, where the rate of sudden unexplained deaths in those 
with SCT was 32.2 per 100,000; compared to 1.2 per 100,000 for African-American recruits 
without SCT.  However, with implementation of better hydration methods and more breaks 
to allow the core body temperature to decrease during exertion, the number of unexplained 
SCT recruit deaths decreased.72 
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1.4 Motivation of thesis 
 Although sickle cell anemia is symptomatically complex, it is simply the consequence 
of a point-site molecular mutation of the glutamic acid residue by a valine in the two β 
subunits of Hb.  However, such a substitution causes the deoxygenated form of the 
molecule to polymerize.  There have been many studies done on how other species of Hb or 
molecules affect polymerization.  For example, studies done on the solubility of HbA and 
HbS mixtures found that HbAS molecules can enter a polymer.  This gives information about 
how polymers form, i.e. a polymer can still form and include HbAS hybrids with only one 
mutation site (but at a large energetic penalty).73 74 Likewise there were studies done on 
deoxygenated HbS at equilibrium, which found that there was little oxygen or CO bound to 
the polymer.75 76  The equilibrium studies can give information such as the probability for a 
partially saturated HbS molecule to be in a polymer, but they do not provide information on 
how that molecule affects the polymerization or nucleation rates.  Until now, there have 
been no studies which measure the homogeneous and heterogeneous nucleation rates of a 
partially saturated CO or oxy HbS solution. 
Studying nucleation rates gives an important piece of information that is applicable 
to understanding the structural formation of nuclei as well as a therapeutic understanding 
of how quickly polymer masses grow under these conditions.  Nevertheless, most of the 
studies done on the nucleation rates of HbS have been for pure HbS solutions, such as 
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completely deoxygenated HbS.  There are some studies done on hybrid molecules, such as 
HbS and HbF mixtures, and HbS and HbA mixtures.77 78  The hybrid studies have shown that 
the rate of formation of the HbS nuclei were different from what was predicted.  In the case 
of HbS and HbF mixtures, the benefit of having a non polymerizing species (HbF and HbSF 
hybrids) was partially counteracted by the crowding of the HbF and HbSF molecules.  This 
meant that polymerization did not decrease by as much as had been expected.  In the case 
of HbS and HbA mixtures, HbAS hybrids can enter the polymer, while HbA cannot.  It was 
found that to form a homogeneous nucleus, there must be at least one pure HbS molecule, 
while for the heterogeneous nucleus, even a greater number are required.  However, 
despite this the overall nucleation rates of HbS and HbA mixtures were faster than 
predicted. 
 Considering this, the objective of this thesis is two-fold, first, to measure the 
nucleation rates of partially saturated CO HbS; and second, to measure the nucleation rates 
of partially saturated oxy HbS.  Due to the ability of photo dissociating CO from HbS, 
multiple saturations can be measured on one sample and a larger amount of data can be 
collected.  How will the homogeneous and heterogeneous nucleation rates of oxy and CO 
HbS compare?  Once the nucleation rates are understood, therapeutic questions which can 
be answered with this information.  The motivation for the thesis work will be discussed 
again after the literature review. 
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1.5 Clarification of Language, Mixtures and Partials 
 Hybrids refer to HbS and another species of Hb such as HbA or HbF which has 
dimerized and recombined into a new molecule such as HBSF or HBSA.  Where one α β 
dimer is HbS and the other is from the HbA or HbF. 
Partial ligands refer to a Hb molecule that is carrying less than the total 4 ligands, i.e. 
either 3, 2, or 1.  Zero ligands are referred to as the unliganded state, or deoxy-Hb. Deoxy 
Hb is the term used for the unliganded form of oxy Hb or CO Hb.
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Chapter 2:  Hemoglobin Allostery and Kinetics 
 
2.1 Derivation of polymerization equations 
 Sickle hemoglobin polymers grow through a double nucleation pathway.79  Initially, 
there are deoxygenated HbS monomers in a solution that will start to form small 
aggregates.  Aggregation is not favored by entropy due to the loss of motional freedom, but 
is energetically favored by the decrease in free energy caused by the intermolecular bonds 
made by the HbS monomers.  Once an aggregate reaches a certain minimum size (the 
nucleus), more contacts are available to each molecule and aggregation becomes favorable 
(figure [2.1]).  This process produces a homogeneous nucleus (a nucleus that is formed only 
from the monomers in the solution).  Forming a homogeneous nucleus is a stochastic 
process; therefore, it is characterized by a variable delay time, before which aggregates 
cannot be detected.  If however the volume of the solution is high enough, the formation of 
a nucleus can be deterministic, appearing to not have stochastic behavior. 
Heterogeneous nucleation occurs through nucleation on preexisting polymer 
surfaces.  It cannot occur until homogeneous nucleation has already taken place.  The more 
polymer surface which becomes present, the more sites that are available for a 
heterogeneous nucleus.  This accounts for the exponential growth that occurs after a 
nucleus is formed.  Polymers will form until solubility is reached (when polymer and 
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monomer are in equilibrium with each other), or until polymers can no longer grow due to 
end obstruction.80 
 
 
 
 
Figure [2.1]: Energy barrier for the formation of the critical nucleus.81 
 
 
 
  
 When describing polymer kinetics and thermodynamics, it is necessary to consider 
solution non-ideality.  Non-ideality occurs when a mixture of chemical substances deviates 
from ideal behavior.  In ideal mixtures, the interactions between each pair of chemical 
species are the same as though it is interacting with itself.  Therefore, the mixtures can be 
expressed in terms of their concentrations (or partial pressures) much like an ideal gas in 
thermodynamics.  However, if the molecules of the mixture interact with each other, by 
attracting or repelling for example, the concentration will not be an accurate description of 
the species in the mixture. Instead, a modified concentration must be used to describe the 
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mixture, which is done by multiplying the concentration by an activity coefficient.  For ideal 
solutions the activity coefficient = 1, and for non-ideal solutions the coefficient can be > or < 
1 (with > 1 being more volatile and <1 being less interactive). For HbS polymerization to 
occur, the solution concentration must be high.  Since the monomers occupy a large portion 
of the solution volume, the total solution volume is not accessible to all the monomers and 
the aggregates.  This excluded volume causes the activity coefficients to be large. 
 
 
 
Table [2.1]: Definition of terms: 
Symbol Definition 
cp Concentration of polymer ends 
c Concentration of monomer 
f0 Rate of Homogeneous Nucleation 
gΔ Rate of Heterogeneous Nucleation 
γi*+1, γ
‡ Activity coefficient of the nucleus plus 1; Activated 
complex 
γ Activity coefficient for monomers 
γi* Activity coefficient for the nucleus 
γs Activity coefficient for solubility (monomer activity in 
equilibrium with the infinite polymer) 
cs Solubility concentration 
k+ Monomer addition rate 
ci* Concentration of homogeneous nuclei of size i* 
Δ Concentration of monomers in polymers 
J Elongation rate of the polymer 
Ki Equilibrium constant for formation of the i-mer 
c0 Initial concentration of monomers 
φ Proportionality constant of nucleation sites per 
polymer 
δ1 Fraction of intermolecular bonds relative to the infinite 
polymer 
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The derivation of the homogeneous and heterogeneous rate equations have been 
described in great detail elsewhere.82 83  Here, key parts of the derivation will be shown and 
elaborated upon.  Below follows the derivation found in chapter 23 of Disorders of 
hemoglobin: kinetics, pathophysiology, and clinical management, page 596.84 
The concentration of polymers (cp) changes over time, due to contributions from 
homogeneous and heterogeneous nucleation.  Below is the main kinetic equation: 
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The formation of polymers through the homogeneous pathway depends on the monomer 
addition rate, the activity coefficients of the nucleus, and the monomer, and nucleus plus 1.  
For the homogeneous nucleus, the activity coefficients can be assumed to be for a spherical 
object and calculated from scaled particle theory:85 
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With the equilibrium condition between the nucleus and the monomers as: 
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and    as defined in table [2.1]. 
The heterogeneous growth rate is similar to the homogeneous rate (the i is replaced with a j 
to show that this is heterogeneous) except that the nucleus is now attached to the polymer 
and is no longer a spherical object, this is indicated by the prime. 
[
   
  
]
   
   ( )  
            
      
     (2.4) 
 
 
The concentration of homogeneous nuclei,     can be written as: 
          ̃ (    )(  )
   (2.5) 
 
This is a consequence of the two step heterogeneous nucleation.  First, the formation of a 
  -mer in solution with equilibrium constant   ̃.  Second, attachment of the  
 -mer to the 
polymer with an equilibrium constant   .  With    as defined in table [2.1] and  is the 
proportionality constant which gives the number of nucleation sites per polymerized 
monomer. 
The concentration of monomers in polymers can be written as: 
  
  
   (       )      (2.6) 
 
Defining the elongation rate of a polymer as: 
  ( )    (       )  (2.7)  
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allows one to write equation (2.6) as: 
  
  
  ( )   (2.8) 
 
 
The equations can be expanded about the initial concentrations, and keeping the first order 
terms gives:86 
   
  
   (  )  [ (  )  
  (  )
   
]   (2.9) 
 
 
From there the growth rates can be separated and solved: 
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With   as the ratio of activity coefficient for a polymer without polymer attached to the 
activity coefficient of a polymer with aggregate size      (         
 ).  The analytic 
solution to equations (2.10) and (2.11) are: 
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With the A and B terms then given by: 
    [  
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    is independent of heterogeneous nucleation, and can be defined as: 
         (2.15) 
 
Below is a plot of B2A at 25° Celsius for different concentrations of HbS solutions.  B2A is only 
dependent on homogeneous nucleation.  
 
 
 
Figure [2.2]: B2A dependence on concentration for 25° Celsius.87  
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2.2 Derivation of chemical potential of HbS nucleation 
 When deoxygenated HbS polymerizes in solution, it will eventually reach 
equilibrium between the monomer and the polymer phase (figure [2.1]).  The concentration 
of the monomers left in the solution is called the equilibrium solubility, cs.  The activity 
coefficient, γi describes how the interactions between the monomers change with 
concentration, i.e. as concentration increases to solubility, there is crowding in the solution 
and the surface to surface rather than the center to center interactions must be taken into 
account.  So in terms of the chemical potential, the equilibrium between polymer and 
monomer can be written as: 
          (2.16) 
 
Where μ1 is the chemical potential of the monomer and μi is the chemical potential of the i-
mer.   
 
Figure [2.3]: Equilibrium between monomer and polymer states. 
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 The chemical potential of monomer is expanded into the rotational   , and 
translational    terms; while the i-mer is expanded into rotational, translational, 
intermolecular bonding between monomers, and vibrational terms (                
respectively).  The monomer chemical potential and i-mer chemical potential then become: 
             (  ) (2.17) 
 
Where γ is the activity coefficent of the monomer; T is the temperature and k is the gas 
constant.  Generalizing this to the i-mer: 
                       (    )   (2.18) 
 
Expanding equation 2.16 with these terms and separating the   (    ) term: 
             (  )                      (    ) (2.19) 
  (    )     (  )   (     )                   ⁄            (2.20) 
 
Since the chemical potentials are constants, this equation can be written as: 
      (  )
   (2.21) 
 
where K contains the constant terms, thus making it the equilibrium constant between 
monomers and i-mers.  So equation 2.16 can be written as:  
                          (2.22) 
 
Finally, it is important to define the critical nucleus size referred to in figure [2.1].  Clearly, 
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the critical nucleus is reached when the derivative of the Gibbs energy over the number of 
monomers is zero.  This means that the chemical potential of the i-mer, i.e.           can be 
set equal to zero and solved in terms of the supersaturation:  
   
 
   
  (2.23) 
 
Where S as the ratio of the HbS concentration to the solubility concentration, 
              (2.24) 
 
When the concentration at which solubility occurs is low, then the supersaturation is high, 
and the critical nucleus size is small.  The term   is a constant which is: 
     
     
  
     (2.25) 
 
Where    is the parameter which describes the fraction of intermolecular bonds in the 
nucleus relative to the infinite polymer. 
 
2.2.1 Understanding HbS growth curve distributions 
The nucleating event of HbS is governed by stochastic behavior, therefore to 
appropriately analyze the system, a large amount of data must be collected.  In vivo, the loss 
of oxygen from the RBC is not instantaneous.  This is because oxygenated HbS monomers 
will be mixed with deoxy HbS, thereby lowering the rate of polymer formation.  However, in 
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vitro it is possible to deoxygentate a sample of CO-HbS within milliseconds,88 almost 
instantaneously in comparison to the time it takes the first nucleus to form (which can be 
from a half second to several minutes).89  It was found that polymerization could be induced 
in HbS samples saturated in carbon monoxide, via photolysis with 1 Watt 428 nm laser (with 
a maximum of 3.1 kW/cm2 intensity).  This method has the advantage of allowing the 
polymers to melt when the laser is turned off, by allowing the CO to rebind to the HbS.  The 
experiment can then be repeated in the same area many times.  In addition to this, the laser 
used is passed through a mesh with many small holes.  Such a device creates many sample 
areas that each will produce nuclei and polymers independent of its neighbors.  As each 
spot grows polymers, they will in turn scatter some of the laser light used to create them.  
This scattered light is collected and are the data for “growth curves” of the polymers.  An 
example of the kinetic growth curves is pictured in figure [2.4]: 
 
 
                                                          
88
 Ferrone, F. A., Hofrichter, J., Eaton, W. A.:(1985). Kinetics of Sickle Hemoglobin Polymerization, II. A 
double nucleation mechanism. J. Mol. 183:611-631. 
89
 Hofrichter, J. (1986). Kinetics of sickle hemoglobin polymerization: III. Nucleation rates determined from 
stochastic fluctuations in polymerization progress curves. J. Mol. Biol. 189:553-571. 
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Figure [2.4]: Growth curves of polymers via scattered light. 
 
 
 
The data in figure [2.4] can be used to find the exponential growth B of the curves by fitting 
the first 10% of the curve to an exponential function: 
 ( )  
 
 
[     ]   (2.26) 
 
where A is a constant.  By plotting a histogram of the tenth times, a curve can be fit to the 
distribution (figure [2.5]) and the homogeneous nucleation rate,    can be found (more 
details on this in section 2.3.2). 
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Figure [2.5]: Examples of     probability distributions.
90  
 
 
  
As an example of how the B and    parameters affect the probability distribution, 
observe the top two figures in [2.5] above.  In figure (a), the solid curve extends further then 
the dotted line (which is the solid curve in figure (b)), likewise in (c) and (d).  This stretching 
of the    ’s is due to the increase in the homogeneous rate. If the nucleus takes a longer 
time to appear, the probability distribution will stretch, due to the increased number of 
possible times for the nucleus event to occur in. Now compare the axis of the two figures on 
the left of [2.5].  The center of the distribution in (a) it is ~0.3.  In figure (c) it is ~0.8.  The 
                                                          
90
 Aprelev, A. et al. (2005). The effects of erythrocyte membranes on the nucleation of sickle hemoglobin. 
Bio. J. 88:2815-2822. 
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center of the distribution will shift right due to heterogeneous growth taking a longer time 
to occur. 
 
2.2.2 Fitting stochastic growth curves through the Szabo formulation 
 HbS polymerization can be related to classical stochastic nucleation theory.  
However, in our system we have a heterogeneous nucleation and growth that can, for 
example, prevent more than one homogeneous event from occurring.  This is because all 
the available HbS could have been used in making heterogenous polymers, therefore not 
allowing a second homogeneous event to occur.  A stochastic nucleation theory would have 
to take this into account when describing our system. 
 In 1988, Szabo laid the groundwork for the analytic model we use to describe HbS 
nucleation91.  He began by defining the average number of monomers incorporated into a 
polymer as the sum of n times the probability that there are n monomers incorporated: 
〈 ( )〉  ∑    ( )
 
     (2.27) 
 
For our system, if    
is the homogeneous rate of polymer formation and B is the 
heterogeneous rate, then if there are n monomers incorporated in a polymer at time t, then 
in     , either a new nucleus can form, or a present nucleus can grow.  Note that a larger 
nucleus has more contacts and can grow proportional to n.  The probability that there are n 
monomers in a polymer at time      is the sum of the probabilities of those two growth 
                                                          
91
 Szabo, A. (1988). Fluctuations in the polymerization of sickle hemoglobin: A simple analytic model. J. of 
Mol. Biol. 199:539-542. 
52 
 
rates.  However, there is also the possibility that no new monomers were absorbed in time 
t.  Considering this, the equation then becomes: 
  (    )      ( )(    (   ))     ( )(  (     )     (2.28) 
Szabo uses mean first passage time theorem to find an expression for nc, the critical nucleus.  
Letting Qk(t) be the probability that nc has not been reached by time t (   ( )   ), with k 
as the number of monomers in a polymer.  Then,   ( )    and: 
   ( )
  
 (     )(    ( )    ( ))  (2.29) 
 
The distribution of the times to reach nc from n can be written: 
  ( )   
   ( )
  
 (2.30) 
 
Szabo differentiates (2.29) with respect to t, and uses a Laplace transform to find an integral 
form for  ( ), and lets    ( )   .  He uses this and solves the recurring series solution of 
the Laplace transform to obtain: 
  ( )  
  (      ⁄ )
 (  ) (   ⁄ )
     (      )       (2.31) 
 
where Γ() is the gamma function.  For our system we can only observe the nucleus when it is 
already grown to an amount much larger then nc.  When nc is taken to be large (nc ≈ n) this 
expression becomes: 
 ( )  
    ⁄
 (  )⁄
(      )      (2.32) 
  
In our system,        .  Where   is Avogadro’s number and    is the rate constant for 
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primary nucleation.  When this equation is fit to the distribution of tenth times for a given 
sample, the 
0f can be solved.  From Szabo’s expression for tenth times, the B term 
dominates until some time when t > 1/B when the     term will dominate the distribution.   
 
2.3 Hemoglobin allostery, occupied ligand populations calculations 
Allostery refers to the changes in the shape and activity of a molecule due to the 
binding of ligands to that molecule.  The partially saturated HbS experiments conducted in 
this thesis required the allostery of HbS to be defined in order to fully analyze the data.  The 
CO and oxy samples are measured at different partial pressures and the ligand populations 
at each of these partial pressures can be solved through the allosteric model for 
hemoglobin.  Hb exhibits positive cooperatively when binding ligands.  This means that the 
presence of the first ligand will assist in the binding of the second and so forth for the four 
ligands.  Cooperativity  is what gives the binding curve of oxygen it’s  well recognized “S” 
shape (figure [1.6] left).  The MWC (Monod, Wyman and Changeux) model is used to 
describe the binding kinetics of a molecule which can be in two states, R (relaxed) and T 
(tense) state and is used to describe the cooperative binding of ligands to Hb.  In any single 
molecule all the subunits must be in the same state, either R or T.  The R state has a higher 
affinity for the ligand than the T state.  However, the binding of any ligand is assumed to 
take place at identical sites whose affinity is only determined by the allosteric form, R or T.  
This model can affectively be used to illustrate the binding of ligands to HbS and is 
supported by structural studies which also show that Hb does have two forms, R and T.   
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The generalized form for the derivation of the binding polynomial is obtained from 
Gill and Wyman’s book Binding and Linkage (p 133) through the formulation of the MWC 
model.92  However, the Adair binding constants, the liganded HbS populations, and the 
special case for DPG, are all uniquely derived for this thesis work.     
 Unliganded R and T forms are denoted with an R or T subscript and the equilibrium 
constant for the unliganded reaction is given as: 
  →    (2.33)                                                                                              
 
The equilibrium constant    describes the transition between the two unliganded allosteric 
forms: 
   
[  ]
[  ]
    (2.34) 
 
The binding of ligand “X” in each of the forms may be expressed in a two column array.  
Where the arrows show that the macromolecule can transition between R and T states, as 
well as bind ligands: 
   
→    
             
    
→     
              
     
→      
               
                
               
    →      
                                                          
92
 Wyman, J., Gill, S. (1990). Binding and Linkage: Functional Chemistry of Biological Macromolecules. 
University Science Books. 
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This shows a system that can bind up to t ligands of molecule X.  The two binding equations 
can be written as: 
    →                   
[   ]
[  ] 
   (2.35) 
    →                    
[   ]
[  ] 
   (2.36) 
 
 Where   and    are the equilibrium constants of binding ligand X to the R or T state 
respectively.  The degree of binding of the first ligand (in both the R and T state of the 
molecule) can be written as: 
 ̅   
[   ] [   ]
[  ] [  ] [   ] [   ] [    ] [    ] [    ] [    ] [    ] [    ]
  (2.37) 
Substituting the equilibrium equations gives: 
 ̅  
       
                                                  
   (2.38) 
The binding partition function Q, can then be written as: 
  (     )
    (     )
   (2.39) 
where t is the total number of possible bound ligands (4 for hemoglobin).  The binding 
polynomials for R and T can be simplified as: 
   (     )
  (2.40) 
   (     )
  (2.41) 
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And the binding partition function can then be written as: 
           (2.42) 
 
Until now, the derivation of the binding polynomial has loosely followed what was 
presented by Gill and Wyman in the book, Binding and Linkage.  However, for our system, 
we will derive the number of each Hb species with each amount of ligands (zero to four) in 
the R and T forms, and we will also consider the special case of additional DPG.  DPG only 
affects the binding of ligands when Hb is in the T-state, and so the equilibrium of the binding 
of DPG:      is only multiplied by   .  This changes the binding partition function to: 
                 (2.43) 
 
where      is equal to the equilibrium between R and T multiplied by the binding rate of 
DPG and the concentration of DPG: 
             [   ] (2.44) 
 
 
This binding polynomial can be written out for t =4 ligands, which is the case for Hb: 
  (     )
    (     )
      (     )
  (2.45) 
 
Once the total binding polynomial is obtained, it should be normalized to the sum of all 
unligated species: i.e when t=0: 
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(     )
    (     )
      (     )
 
         
 (2.46) 
 
For simplicity let the normalization be replaced by N: 
            (2.47) 
 
From the binding polynomial a lot of useful information can be extracted about the system, 
including the Adair constants, the binding curve, the Hill Plot, as well as the species fractions 
in R and T at a given saturation of x.  With a little bit more work, one can also extract the 
species fractions that are in R or T with 0, 1, 2, 3 or 4 ligands (i.e.                     
                    ). 
An alternative way to describe the binding of a ligand to the molecule is with the  
Adair binding constants:    .  They are the stoichiometeric coefficients that describe the 
binding process in terms of overall reactions to the unliganded molecule.  Here are they are 
for the R0 to R1 and R0 to R2 ligand bindings: 
    →                   
[   ]
[ ] 
  (2.48) 
     →                     
[    ]
[ ]  
  (2.49) 
 
 
The Adair constants are found by expanding the binding polynomial and grouping 
coefficients of the same powers.  Expansion of the terms in P gives: 
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 (2.43) 
 
The Adair binding constants for the T states are: 
    
       
 
 (2.45) 
 
    
             
 
  
 
    
     
         
 
 
  
 
    
     
         
 
 
  
 
    
    
        
 
 
  
 
and for the R states: 
    
 
 
  (2.46) 
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The activity coefficients,        are the species populations of how many HbS have that 
number of ligand i in form h (where h is R-state or T-state) for a given oxygen pressure (x).   
    
    
 
 
   (2.46) 
 
Solving for    
   : 
    
 
 
     
       
 
  (2.48) 
 
    
(   ) 
 
      
(             ) 
 
  
 
    
(   
 )  
 
      
(     
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(     
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(  
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(    
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Plotting the αhi’s for CO Hb will show all the Hb to be in state T0 at zero CO pressure.  The T 
states are unpopulated at high CO pressure (figure [2.6]), because most of the Hb will be in 
the R-state.  Figure [2.7] below shows the total αR plotted with the total in αT.  The values 
used in creating these plots are: L0: 3.08e5,  
  
  
      and [DPG]=0 (DPG is insignificant in 
the case of CO Hb binding). 
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Figure [2.6]: Fraction of HbS in T state 
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Figure [2.7]: Fraction of Hb in T-state and R-state. 
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Chapter 3:  Literature review 
 
 
As mentioned in chapter 1 section 4.2, there were already studies done on the 
equilibrium of partially liganded CO and O2 HbS.  Small amounts of O2 and CO were found in 
gelled deoxygenated HbS.  In this chapter, two extensive experiments will be reviewed and 
used as examples for the motivation for this thesis work. 
 
3.1 Ligand binding and the gelation of sickle cell hemoglobin, Hofrichter 
In 1979, James Hofrichter would publish an extensive study of CO in gelled HbS 
solutions.93  At the time of publication completely deoxygenated HbS gels had already been 
studied.94  It was known that there was a delay before polymers would appear,95 and that 
this delay was related to the 40th power of the concentration.96  However, these studies 
were done on large volume HbS samples, which would nullify the stochastics of 
homogeneous nucleation.  The double nucleation growth pathway was also not defined at 
this time.  Even so, such knowledge was not necessary in order to study the characterization 
of HbS in gels. 
For many years there has been great interest in relating in vitro HbS experiments to 
the in vivo environment.  Studying partially liganded HbS solutions is one approach of many.  
                                                          
93
 Hofrichter, J. Ligand binding and the gelation of sickle cell hemoglobin. J. Mol. Biol. 1979. 128, 335-369. 
94
 Hofrichter, J. Ross, P. D., Eaton, W. A.: Kinetics and mechanism of deoxyhemoglobin S gelation: A new 
approach to understanding sickle cell disease. PNAS. 1974. 71(12) 4864-4868. 
95
 Eaton, W. A., Hofrichter, J., Ross, P. D., et al. Comparison of sickle cell hemoglobin gelation kinetics 
measured by NMR and optical methods. Biochem. Biophys. Res. Commun, 69 (1976), pp. 538–547. 
96
 Eaton, W. A., Hofrichter, J., Ross, P.D.: Delay time of gelation: a possible determinant of clinical severity 
in sickle cell disease. Blood. 1976. 47, 621-627. 
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At the time of Hofrichter’s publication, there were already some other studies done on 
oxygen and HbS.  It was already shown that HbS cells could sickle at high oxygen fractional 
saturations.97  And that oxygen affinity decreases with increasing cellular concentration due 
to the polymerization of deoxy HbS.98  Hofrichter’s work would show that HbS polymers are 
composed of mostly unliganded deoxygenated T-state HbS, with a very small fraction of 
liganded COHbS in the gelled polymers. 
Hofrichter used three techniques in his study of CO HbS gelation.  These were 
sedimentation, linear dichroism and turbidity.  Sedimentation is a technique which 
centrifuges large volumes (~330 ul) of deoxygenated HbS.  Polymers and monomers will 
reach equilibrium in solution, and the centrifugation sediments the polymers and allows the 
supernatant to be measured.  For a mixture of deoxy HbS and COHbS, the concentration of 
CO in the original solution and in the supernatant is used to find how much CO is in the 
polymer.  Linear dichroism is a spectroscopic technique that uses the difference between 
parallel and perpendicular polarized light to measure the composition of aligned polymers.  
It is one of the few techniques that can measure the absorption of polymers when there are 
monomers in the solution, because it is only sensitive to the aligned polymers. 
Samples for this experiment were prepared by exposing a small amount of HbS to 
CO.  This was then mixed with a larger amount of oxy HbS.  After thorough mixing, the 
sample’s concentration was determined through dilution.  The oxy/CO HbS mixture was 
then mixed with dithionite, which converts the oxy HbS to deoxy HbS as well as kept at a 
low temperature.  The samples were large volume samples of about 350 µl in a sealed 
                                                          
97
 Bookchin, R. M., Balazs, T., Landau, L. C.: Determinants of red cell sickling.  Effects of varying pH and of 
increasing intracellular hemoglobin concentration by osmotic shrinkage.  J. of Lab. And Clin. Med. 1976. 
87(4): 597-616. 
98
 May, A., Huehns, E. R., The concentration dependence of the osxygen affinity of haemoglobin S. Brit. J. 
of Haem. 1975. 30(3) 317-335. 
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quartz vial.  It was possible to measure the spectrum of the samples in the sealed vials to 
determine the final deoxy HbS concentration, the CO heme concentration of the sample can 
also be determined.  The samples are then allowed to increase in temperature till they gel.  
They are then centrifuged till there is sedimentation of the polymer.  The supernatant can 
then be measured for the amount of CO.  If it less than the amount measured previously, 
that is an indication of CO present in the polymer.  When the sedimentation experiment is 
concluded, the polymers are melted and mixed at a lower temperature.  A small amount of 
the solution, 1-2 µl was then used to make 3 or 4 slides in a nitrogen atmosphere.  These 
samples were warmed until they gelled and then were measured via linear dichroism. 
The solubility experiment is analyzed by studying the supernatant after 
sedimentation is completed from the centrifugation.  The deoxy heme concentration of the 
supernatant and pellet and the volume fraction of the pellet are measurable quantities.  The 
concentration of deoxy hemes in the supernatant decreased with increasing saturation of 
CO Figure [3.1] bottom.  This was believed to be due the increase of copolymerization of CO 
HbS and not due to less efficient packing of the pellet at higher concentrations. Linear 
dichroism can detect spectra changes as small as 0.5%.  The dichroism spectra were 
normalized by dividing through with a pure deoxy polymer spectrum.  The samples showed 
only a small contribution from CO which increased monotonically with fractional CO 
saturation, data in figure [3.1]top. 
The data was analyzed by first defining what the fractional species of CO HbS in the 
sample are.  In figure [3.2], two different sets of allosteric parameters were used to build 
these curves.  Then, when the number species of HbS with 1, 2, 3 or 4 liganded CO is known 
for each percentage of CO in the sample, it can be compared to what was found in the 
polymer and solution.  For example, a sample with 40% CO initially would have about 8% 
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with three and two ligands, 21% with one ligand and 38% without ligands (the dotted lines 
in the left figure).  Since the fraction of polymer is known as well as the concentration of 
deoxy HbS in the supernatant, it is possible to build a model for what liganded species if any 
are in the polymer. Figure [3.1] top and bottom show different models being fit to the data 
points. 
The top figure of [3.1] shows the results from the analysis of the linear dichroism 
study and the bottom is the results from the equilibrium experiments.  The dotted lines on 
the two graphs show an analysis for all T states being in the polymer, regardless of degree of 
ligation.  There are two lines because they come from two different sets of allosteric 
parameters.  The upper curve has L=105, KT/KR=c=0.01; the lower, L=10
7, KT/KR=0.002 where 
KT/KR is equivalent to c.  The long dashed line (almost flat to the x-axis) is the prediction for 
only unliganded HbS T states entering a polymer.  The solid lines represent T0 polymerizing 
and the other liganded T-states polymerizing with differing probabilities.  In the top figure of 
[3.1], the upper solid line has parameters L=105, c=0.01, eT=0.25 and the lower line, L=10
7, 
c=0.002, eT=0.3 with eT being adjusted in increments of 0.05.  Where eT is the partition 
coefficient for the partially liganded T-state species.  The bottom graph has the same 
parameters for the dotted lines.  The long dashed line has L=105, KT/KR=0.01, the upper solid 
line has L=105, KT/KR=0.002 and eT=0. 
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Figure [3.1]: Top: Fitting different theoretical models to the data from the linear dichroism 
experiment.  The error bars increase because as fractional saturation of CO increased, the 
amount of polymer decreased, and therefore the level of noise in the data increased.  
Bottom: Fitting different theoretical models to the solubility experiments.  
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Figure [3.2]: T-state and R-state fraction of species of species versus fractional 
saturation of CO.  Left has allosteric parameters, L=105, KT/KR=0.01, KR=160 torr
-1.  Right 
has L=107, KT/KR=0.002, KR=500 torr
-1.  The three solid lines depict the fraction of 
unliganded T-state molecules (T0), total fraction of liganded T-state molecules 
(T1+T2+T3+T4) and total R-state molecules.  The dashed lines show fractions of 
molecules with 1, 2, 3, or 4 ligands as indicated in the figure. 
 
 
 
From figure [3.1] top, it is clear that the best fit is with the liganded T-states 
polymerizing with differing probabilities.  In the bottom graph in the figure, the data 
appears to be between the differing probability T-states and all T-states entering the 
polymer up until 20% fractional saturation.  Above 60%, the data seems to fit better with 
the model of only T0 states polymerizing.  It is clear that the polymer prefers completely 
unliganded T-state molecules.  In the dichroism experiment in the top graph of figure [3.1] 
the percent of the fractional saturation of CO in the polymer is not above 5% even at 
solution fractional saturations of 70% and the CO increased total solubility by 7%.  However, 
it should be noted that in both the solubility and linear dichroism experiment are measured 
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well after the polymers are completely formed.  This is different from the experiment which 
will be shown in this thesis, which are the nucleation rates.   
How a homogeneous and heterogeneous nucleus form in the presence of partially 
liganded T-states may be different from what is ultimately found in completely grown 
polymers.  However, these experiments show conclusively that there are liganded T-state 
Hb found in polymers.  There is one final experiment that was described in the Hofrichter 
paper.  Each sample was also measured for a delay time in polymerizing.  This was done via 
turbidity measurements on the solubility samples.  As described elsewhere,99 the samples 
were kept in an ice bath and then had their temperatures raised until they could gel.  The 
optical density was then monitored.  Gelation would cause an increase in the optical density 
at 800 nm.  The shortest gelation time measureable is the time it takes for thermal 
equilibrium of the sample.  Figure [3.3] shows how the delay changed with different samples 
at the same total HbS concentration with different fractional saturations of CO.  The data 
with open circles (O) was taken at 35°C and the triangles (Δ) were taken at 20°C.  Between 0 
and 18% saturation increases by a factor of 30 in the high temperature sample and increases 
by 30 between 17 and 36% in the low temperature sample.  The slopes for the two samples 
are identical and for an increase in the fractional saturation from 0 to 40%, the delay time 
increases by about 104.  There seems to be a decrease in slope between 10 and 20% 
fractional saturation, but there is not sufficient data to show this explicitly. 
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 Hofrichter, J. Ross, P. D., Eaton, W. A. Supersaturation in sickle cell hemoglobin solutions. Proc. Natl. 
Acad. Sci. 1976. 73 (9) 3035-3039. 
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Figure [3.3]: log of gelation delay times versus fractional CO saturations for two different 
sample concentrations. 
 
 
 
The delay time experiment results are directly relatable to the kinetics experiments 
conducted in this thesis.  The CO partial photolysis experiments have tenth times measured 
for each % photolysis and concentration.  Tenth times are the time it takes for the mass of 
polymers to scatter 1/10th of the maximum scattered light (or reach 1/10th their final size).  
Since growth of polymers in small volumes is stochastic, the shortest tenth time is the delay 
time. 
 
3.2 Oxygen binding by sickle cell hemoglobin polymers, Sunshine 
In 1982, Helen Sunshine along with Dr. Hofrichter, Dr. Ferrone and Dr. Eaton, would 
publish her results from experiments on the gelation of sickle hemoglobin in the presence of 
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oxygen.100  They would find that the polymer binds oxygen in a non-cooperative manner, 
and has an affinity to bind oxygen which is similar to T-state Hb.  They did two experiments 
on oxy HbS, solubility and linear dichroism.    The solubility and linear dichroism were 
conducted with the same methodology as in the CO HbS experiment.  Before this study, 
experiments on the effect of oxygen on HbS solubility had been conducted on red blood 
cells and whole blood.101 102  These studies showed that inside RBC’s HbS gels had a 
decreased affinity for oxygen.  This was due to formation of polymers inside the gels, 
because in dilute HbS solutions with the concentration below solubility, polymers cannot 
form, and the oxygen dissociation curve is the same for HbS and HbA.103  Although this 
shows that it is the polymers which have a decreased affinity for oxygen, it does not 
quantify the oxygen affinity of polymers. 
To conduct this experiment, it was necessary to develop a technique to decrease 
the amount of met HbS.  Normally 1-2% of oxygenated Hb is met Hb.  However, in a partially 
oxygenated environment, Hb will rapidly oxidize to met Hb.  The met Hb was minimized via 
a met Hb reductase system, and the amount of met Hb was never more than 4%.  However 
this also caused the amount of oxygen in the sample to slowly be consumed.  Due to this, all 
samples were measured with the amount of oxygen as a function of time.  The gelation and 
solubility experiments used HbS which was stored at a temperature between 0 and 4°C and 
then raised to 23.5°C to induce the formation of polymers.  In order to decrease the time it 
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 Sunshine, H. R., Hofrichter, J., Ferrone, F.A., Eaton, W. A.: Oxygen Binding by Sickle Cell Hemoglobin 
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takes for the formation of polymers in the gelled samples for dichroism measurements, an 
argon laser of 3kW/cm2 at 514 nm was focused on the sample which also caused a large 
domain of polymers to form.  In some samples, the amount of polymer formed was so small 
that the samples still appeared to be liquid. For the solubility measurements the samples 
were centrifuged for one hour and had their spectrum taken at intervals for 2 hours.  To find 
the amount of oxygen at the time of sedimentation, the data was extrapolated back to 30 
minutes after the start of centrifugation. 
In the solubility experiment, the supernatant has a decreased concentration due to 
formation of polymers, yet, the amount of oxygen increases.  This shows that the polymer 
has a lower affinity for oxygen.  The solubility was measured for differing concentrations and 
amounts of oxygen.  In figure [3.4], the results of the oxygen experiment are compared to 
the CO HbS data.  The filled circles are the oxygen HbS data and the open circles are the CO 
HbS data.  The upper dotted line is for only T0 states polymerizing the theoretical curve.  
The lower dotted line is for all oxygen T-states entering a polymer.  The solid line is 
calculated from the thermodynamic equation which relates the total Hb activity in the 
solution phase to the Hb binding of oxygen in each phase.  
         
   ∫
     
  
     ̅⁄
     ̅⁄
   
  
      (3.1) 
where         is the solution phase hemoglobin activity at oxygen pressure p.    
  is the 
solution phase hemoglobin activity at zero oxygen pressure.    is the activity coefficient and 
 ̅ is the partial specific volume of Hb.  For the solid line    0.69 g/cm
3,  ̅ = 0.75 cm3/g and 
the specific volume V = 0.92 cm3/g.  The long broken curve is equation [3.1] without 
[(
 
  
)  ̅]
[(
 
  
)  ̅]
, 
which is the solvent term and relates the moles of solvent of Hb in the polymer to the 
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number of moles of solvent per mole of Hb in the solution.  The short broken line comes 
from the least squares of: 
            
     
    (3.2) 
with a = 0.1826 g/cm3, b = 0.0924 g/cm3, c = 0.0980 g/cm3 and d = 0.2352 g/cm3.  This 
equation is used to solve for  , the solution phase saturation. 
 
 
 
 
Figure [3.4]: Solubility data for oxygen (filled circles) and COHbS versus fractional 
saturation.  
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The solution phase saturation is converted to an oxygen partial pressure using the 
binding curve from Gill.104  The oxygen partial pressures were used to make a Hill plot, 
shown here in figure [3.5].  The figure shows the data for a 16 g/dl solution (open circles) 
and 37 g/dl gel (squares are oxygenation and triangles are deoxygenation experiments), the 
crosses are the polymer binding data from the solubility experiment.  The straight line has a 
slope of 0.97 ±0.09.  In a Hill plot for hemoglobin shows how many subunits are interacting.  
A slope of 1 means the hemoglobin is non-cooperative.  The polymer phase had a larger 
affinity for oxygen than for CO.  Sunshine found that the fractional saturation of the polymer 
with oxygen was 1.5 times more than with CO at all saturations of the solution phase.  
However, they were not sure if the discrepancy could be contributed to the different ligand, 
or if it could have been an artifact of the sample making technique.  The CO samples were 
gelled for a much longer period of time and could have crystallized.  This form could have 
caused less CO to be in the polymer phase.  However, when the data for the dichroism 
experiments were compared in figure [3.6] there was good agreement for the affinity of the 
polymer for the different ligands.  However, at the time of these experiments, it was not 
known that gelled samples do not reach complete solubility, whereas in centrifugation 
experiments, solubility is reached.105  This could mean that less oxygen is found in the gelled 
samples because polymers formed with the more favorable unliganded HbS molecules that 
were available.  This could explain why less CO and oxygen is found in the polymer in the 
linear dichroism experiment. 
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Figure [3.5]: Hill plot of the solubility data for the oxygen experiment. 
 
 
 
 
Figure [3.6]: Linear dichroism experiment oxygen experiment.  The broken line is for 
perfectly aligned polymers, open circles are from the CO experiment at 35°C and filled 
circles are the oxygen experiment at 23.5°C. 
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In conclusion, the oxygen experiment shows what appears to be a greater affinity of 
the polymer for oxygen than for CO ligands.  Sunshine would calculate that the probability 
for the oxygen bound T1 state to enter the polymer to be 0.37 and for T2 to be 
approximately (0.37)2.  However, although these studies demonstrate there is oxygen 
present in already formed polymers, it does not explain how the presence of oxygen and CO 
affect the nucleation rate of HbS. 
 
 
3.3 Motivation for thesis work 
The two experiments presented in chapter 3 sections 1 and 2, are equilibrium 
experiments.  The polymer and monomer state of HbS and partially liganded HbS are in 
equilibrium when the measurements are conducted.  Such experiments are fundamentally 
different from measuring the rate at which a homogeneous or a heterogeneous nucleus 
forms.  Although a certain amount of liganded HbS is found in the polymer, it will not 
necessarily explain how the presence of such partial ligands will affect nucleation.  Two 
examples of this are the mixture experiments performed by Rotter et. al. on deoxygenated 
fetal106 and deoxygenated normal adult Hb mixed with HbS.107  In the case of fetal Hb mixed 
with HbS, other experiments had already showed that fetal hemoglobin did not polymerize, 
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nor did fetal/HbS hybrids.108  However, when the nucleation rates were measured, it was 
found that the rates did not decrease as much as expected based on gelled sample data.  
This was because although the fetal Hb and HbSF do not polymerize, they crowded the 
solution.  Although having a non-polymerizing species does decrease the nucleation rates, it 
will be partially counteracted by the crowding species in the solution.  This result would 
have only been a theoretical hypothesis if the experiment had not been done. 
 Other experiments on deoxygenated HbA and HbS mixtures found that the hybrid 
species, HBAS does enter polymers.  However, nucleation experiments would reveal further 
information about the formation of the nuclei in the presence of these hybrids.  It was found 
that the homogeneous nucleus requires at least one pure HbS molecule, and the 
heterogeneous nucleus requires a greater number.  That may be due to the larger number 
of molecules involved in the formation of a heterogeneous nucleus.  The nucleation rates of 
HbAS mixtures were also faster than predicted. 
 These two results demonstrate that experiments on polymer composition can 
provide important information when deoxygenated HbS is not the only species.  
Understanding why polymers can contain HBAS hybrids, but not HBSF is useful in 
understanding the alignments of the hydrophobic pockets which allow the polymers to form 
(chapter 1 section 3.3).  However, these experiments do not completely predict the 
behavior of the system in the case of nucleation.  Therefore, it is necessary to measure the 
nucleation rates of partially saturated CO and oxy HbS solutions in order to either reaffirm 
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or contribute more information to what is already known.  The two experiments conducted 
in this thesis are on partially saturated CO and oxy HbS samples.   
 
 
3.4 Nucleation rates of HbS partially saturated with CO and oxygen 
 The CO HbS experiment is conducted by making samples of HbS in which the only 
ligands in the system are CO.  Laser photolysis, a technique which uses the ability of a laser 
at a particular frequency (488 nm in this case) to push the CO out of its illuminated or 
“photolyzed” region, will therefore create an area of deoxygenated HbS (unliganded HbS) in 
a sample (chapter 4 section 4.2).  The deoxygenated HbS will form into polymers, which will 
then scatter some of the laser light.  The scattered laser light is then captured by a CCD 
camera and related to the polymer’s growth.  Due to the stochastic nature of the formation 
of nuclei, a large amount of data needs to be collected.  This is done by passing the laser 
light through a mesh with holes of about 10 um in diameter, with the consequence that 25-
35 experiments can be conducted simultaneously.  The size of the illuminated laser spots on 
the sample allow only for only 1 homogeneous event to occur.  This is because a polymer 
mass has already grown (due to the exponential growth) before another homogeneous 
nuclei will have the opportunity to form.   Previously, numerous experiments were done by 
Ferrone et. al. in which the laser completely deoxygenated, i.e. removed all the CO from the 
HbS in the photolyzed region.  However, prior to this, experiments on partially saturated 
samples were not done due to the complicated nature of measuring partially saturated 
areas. 
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 To measure a partially saturated sample, it is necessary to have a range of laser 
intensities across the sample, in order to produce varying areas of partial saturation.  For 
example, this may produce a range of 10-20% saturation.  This means the next data set 
which will be measured can have the laser adjusted to produce 20-30% saturation.  It is less 
time consuming to gather a large amount of data through this method, thereby obtaining 
more varied percentages, as opposed to measuring a single percent at each laser intensity.  
This also means that the laser intensity at each photolysis area must be measured.  This is 
necessary because the intensity at each area can be related to the amount of saturation 
which is present in that area.  To measure the intensity, the laser light was passed through 
the optical system and focused at the sample.  The mesh was removed and a diaphragm was 
inserted, creating a single spot of light.  The power of the laser light at the sample is 
measured through an optical power meter.  The size of the spot is found by taking pictures 
of it with the CCD camera and relating the pixels to microns.  This was then used to find the 
area of the spot and the power density.  This image is also used to make a relation between 
the intensity captured in a pixel on the CCD camera image and the intensity in that place in 
the sample.  Finally, the percent of saturation was directly measured through a single 
wavelength optical technique (chapter 4 section 5.2).  The optical absorbance of hemoglobin 
changes depending on whether it has any ligands, such as CO bound.  The best way to 
measure the composition of a sample is to take its spectrum within a well defined range.  
However, to do so in this case would take too long (~ 1minute) and within that time 
polymers will most likely have formed and the composition of the area changes.  Therefore, 
a method of quickly measuring the components of the solution is necessary.  Inspired by a 
technique which had been previously used to measure the complete deoxygenation of HbS, 
a new technique was created to measure the percent of deoxygenated hemoglobin and CO 
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saturated hemoglobin.  This technique captures images of the sample with the laser on and 
off and can then use the difference in optical densities to solve for the amount of saturation.  
Programs were created in IPLab to control the opening of the laser shutter and the imaging 
capturing with the CCD camera.   
 After obtaining the images of laser intensity and percent saturations, there also 
must be a way to analyze this data (chapter 4 section 5.3).  Currently there are commercial 
software packages, such as ImageJ, which can calculate the properties of an area an image 
highlighted by a user.  However, consider the 25-30 saturation spots captured at differing 
desaturations, as well as each spot evolving over time, its intensity value, and finally its 
kinetics (scattered light) values evolving over time as well.  Such a massive amount of data, 
which all needs to be sorted, and related (saturation to intensity to kinetics) for each 
individual spot, cannot be analyzed by a simple software such as ImageJ.  Therefore, 
extensive image analysis programs were written in Matlab to study and tabulate all of the 
collected data. 
 The partially saturated oxygen experiments were conducted by making samples 
with both CO and oxygen ligands.  The CO is laser photolyzed off the HbS leaving only the 
oxygen ligands.  The samples for this experiment were made differently than the CO HbS 
samples.  It was found that mixing CO HbS with oxygenated HbS, and diluting with 
deoxygenated buffer produced a mixture with a very low amount of free CO or oxygen in 
the solution.  This allowed the photolyzed regions to not have free oxygen in the solution 
rebind with the deoxygenated HbS.  To measure the saturation in these samples, a spectrum 
is taken while the HbS is photolyzed with the laser, in order to find the amount of oxygen 
left in the photolysis spot.  Although measuring the kinetics of the oxygenated sample is 
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simpler than a partial CO HbS sample, there is a great limitation that each oxygen sample 
has a fixed percentage of oxygen.  For this reason, there are fewer data points for the 
oxygen experiments. 
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Chapter 4:  Experimental Work 
 
 
4.1 Chromatography of hemoglobin 
Chromatography is a process used to separate mixtures into its constituent 
components.  Cellular Hb is separated into its various components through ion exchange 
chromatography.  This is accomplished via a column, or a tall cylindrical tube filled with a 
nonreactive medium such as cellulose.  The material in the column is equilibrated to a fixed pH.  
The cellulose in the column remains stationary while a Hb mixture poured into the column will 
flow down through the cellulose at varying speeds due to differing attractions to the ions in the 
cellulose.   
 
4.1.1 Preparation of Hb for chromatography 
Blood was collected fresh from an anonymous donor undergoing transfusion at the 
Children’s Hospital of Pennsylvania.  Approximately 25 ml of blood was transferred into 6-50 ml 
centrifuge tubes and initially mixed with 25ml of 0.9% NaCl (saline) solution.  This was spun at 
2,500 RPM (~790 g’s) for 20 minutes.  The supernatant was then discarded; the tubes were filled 
again to 50 ml, capped and spun again.  This was done for a total of 3 times.  After this, the 
packed RBC’s must be diluted and have a final salt concentration of 2%.  The packed RBC’s were 
mixed with a small amount of (1.5 ml) of 15% NaCl and then diluted with 2% NaCl to ~60 ml 
volume.  The RBC solution was then transferred to large volume cryogenic vials (15 ml) and 
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dipped into liquid nitrogen for 30 seconds and then allowed to thaw in the fridge (figure [4.1]).  
Due to the larger volumes, thawing took several hours.  This process ensures lysing of the RBCs. 
 
 
 
                
Figure [4.1]: Left: Dipping cryo-vials of blood in liquid nitrogen. Middle: The column in the 
fridge. Right: the column loaded with Hb. 
 
 
 
Hb/lysed RBC mixture is then transferred again into 50 ml vials and spun at a very high 
velocity, 14,000 RPM for 1 hour.  This creates a thickened glob of cellular material at the bottom 
of the vials.  The Hb was poured out, the vials were cleaned and the process was repeated 1 to 2 
more times depending on the amount of cellular material which needed to be extracted.  After 
this, the HbS saline solution is mixed with approximately 3 times its volume of Tris buffer that 
has a pH of 8.0.  If the volume of the HbS solution was too large, it was concentrated in a 10K 
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pore membrane concentrator.  The HbS Tris solution was poured into dialysis tubing which had 
been sterilized by boiling in EDTA and then rinsed in double distilled water.  The tubing was then 
suspended in a large volume beaker (4L).  The HbS is then dialyzed against pH 8.5 Tris buffer 
which is 60 times the volume of the Hb.  It is stirred in the cold fridge for 2-3 hours and pH 8.5 
Tris buffer is exchanged twice more.  When dialyzing the solution inside the dialysis tubing will 
grow in volume.  After this, the Hb was concentrated again so as to facilitate easy loading of the 
column (figure [4.1] right).  In the preparation shown in the pictures above, the column is kept in 
the cold so as to minimize the formation of met Hb.  The Hb solution will be loaded onto the 
column as a concentrated solution of about 20 ml. 
To separate Hb into HbA and HbS, one must first pour pH 8.5 buffered Hb into an 
equilibrated pH 8.5 Tris column.  Equilibration of the cellulose begins with washing it with about 
6 times its volume in pH 8.5 Tris buffer.  The cellulose and buffer is stirred for 20 minutes on a 
magnetic stirrer and allowed to settle for 30 minutes.  The supernatant is discarded and the 
process is repeated for a total of 6 times.  The supernatant should be almost clear at the 
conclusion of washing.  The column is poured by stirring the cellulose with a small amount of 
buffer to allow easy flow down a glass rod into the glass column tube.  Equilibration of the 
column’s pH is then continued by passing up to 5 liters of buffer through the cellulose.  The 
cellulose in the column will also settle and decrease in volume overnight.   
When the column is ready for chromatography, the flow of buffer into the column is 
halted until the level of buffer on top of the cellulose is barely visible.  When this has happened, 
the column is loaded with Hb by injecting the hemoglobin in a circular motion around the inner 
walls of the column so as to not disturb the cellulose levels.  After loading the column, the Hb 
will start to separate into a lighter lower band and a darker upper band (HbA2).  After the Hb 
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has fully entered the cellulose, pH 7.35 Tris buffer is added to the column.  The difference in pH 
allows the HbS and HbA to separate further.  The HbS will elute from the column first.  This is 
collected and re concentrated to 4 g/dl.  At this point, the bulk of the HbS can be stored long 
term in the Tris buffer at this concentration in liquid nitrogen.  This is the case for the CO 
experiments.  For the oxygen experiments, the eluted HbS was never stored in liquid nitrogen; it 
was used right away in order to minimize the formation of met HbS. 
 
4.1.1.1 A note on concentrators 
All concentrators used were either 10K or 30K Centricons, ranging in size from 2ml to 
16ml.  They were washed with a 70% Ethanol solution 3x’s at 4500 RPM for 15 minutes.  Then 
the concentrators were washed with distilled water 3 more times at 3000 RPMs for 15 minutes.  
Finally, the solution buffer was used to wash them 3 times at 3000 RPM for 15 minutes. 
 
4.1.1.2 A note on buffers 
For the HbS separation, a large amount of Tris buffer was used at three different pH’s: 
8.00, 8.35 and 8.5 at 0.05M.  Tris buffer is made by adding the liquid to the solid, then adding 
small amounts of HCl while being mixed with a magnetic stirrer.  However, Tris buffer changes 
pH with changes in temperature.  Also, it is necessary to know approximately what the 
temperature of the column will be during the chromatography, because this is the temperature 
at which the three Tris buffers need to have the correct pH.  It is not possible to keep the 
temperature of Tris buffer constant while making it.  This is because the addition of HCl 
increases the solution temperature.  To counteract this, HCl and small amounts of cold distilled 
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water can be added to the buffer until the desired pH at the right temperature is reached.  
Finally, distilled water is added to obtain the correct final volume and 0.05M.  To facilitate this 
process, just one buffer was made at the right pH and temperature.  That buffer’s temperature 
was varied between 18°C and 5.5°C while the pH was monitored so a relation was made 
between temperature and pH.  It was found that pH changed by -0.032 per Celsius degree 
increase.   This method was used to make all the Tris buffers. 
Phosphate buffer is made by first making a stock solution of K2HPO4 and KH2PO4.  Two 
liters of 0.15M K2HPO4 were made by adding 52.25g of K2HPO4 to a container then filling with 
twice distilled water to 2 liters.  Next, 0.6L of 0.15M KH2PO4 was made by adding twice distilled 
water to 12.25 g of KH2PO4.  To obtain a pH of 7.35 or 7.05, a freshly calibrated pH meter was 
placed in the 2L of K2HPO4 and the solution was stirred as the KH2PO4 was slowly added. 
 
4.1.2 Exchanging HbS buffer 
In order to conduct kinetics experiments under pH and salt concentrations similar to in 
vivo conditions, the HbS will be transferred to pH 7.35 phosphate buffer.  To exchange the 
buffer from Tris to phosphate, a pd-10 desalting column is used.  It exchanges through volume 
exclusion.  The column has many tiny pores in which small molecules, such as the molecules in a 
buffer become trapped.  In a vertical column, this means that a large protein such as Hb will flow 
faster through the column via the force of gravity than its buffer.  The buffer that was already in 
the column, in our case pH 7.35 phosphate will then flow out with the protein.  Each column is 
prepared by initially passing 50 ml of phosphate buffer through. When the column is ready to be 
loaded with HbS, the buffer level is allowed to settle to the top of the column.  Then about 300 – 
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400 µl of 4 g/dl HbS is pipetted onto the top of the column.  The HbS is allowed to enter the 
column, then immediately 2 ml of phosphate buffer is added to the column.  When most of that 
has entered the column, more buffer is added (~6-10 ml) to increase the velocity of the flow 
through the column.  The HbS is collected at the bottom of the column and now has a volume of 
~2 ml.  The last few drops of diluted HbS is not collected and allowed to drip into a waste 
container.  The column is then flushed with 50 ml of phosphate buffer and used for no more 
than six exchanges.  To exchange a large amount of HbS quickly, two or three columns are run 
simultaneously with a buffer reservoir on top.  This allows a larger amount of buffer to be placed 
at the top of the column, therefore causing buffer to flow through the column quicker.  At the 
conclusion of exchange, the HbS will then be concentrated again, this time in a small size 
concentrator, either 2 ml or 6 ml volume with either a 30K or 10K pore size.  The final 
concentration should be about 39 g/dl.  About 60-90 µl of this is placed in a 1.8 ml cryogenic vial 
and is either stored in the liquid nitrogen, or in a fridge depending on application. 
 
4.2 Sample preparation 
4.2.1  CO partial photolysis sample preparations 
To prepare a sample for a partial CO photolysis experiment, a vial of hemoglobin in 7.35 
pH phosphate buffer is removed from its storage in liquid nitrogen, and thawed inside the CO 
glove box. The CO glove box is flushed ahead of time with CO for 20-30 minutes.  Approximately 
2 containers of 40 ml of phosphate buffer are flushed with CO in the glove box for no less than 
30 minutes.  This removes oxygen from the buffer solution and replaces it with CO.  When the 
buffer is done flushing, three tubes each with 5 ml of CO phosphate buffer are prepared for 
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testing the Hb composition and concentration.  Before the Hb is diluted for spectrum testing, it 
is stirred and mixed with a micro pipette.   This is done by drawing up 5ul of Hb from the bottom 
center of the conical vial and then releasing it at the top of the 60 µl solution in a circular 
manner.  This is important due to the small volumes in each container (50-100 µl) and the 
possibility of the settling of contents as well as some drying at the surface/air contact.  The 
measurements conducted here can be greatly affected by small changes in concentration, for 
example a 1 g/dl difference in concentration (from 26 g/dl to 27 g/dl) could have a tenth time 
(where the tenth time is one tenth of the time a kinetics growth curve takes to reach its 
maximum value)  decrease from 16 to 5.5 seconds. Similarly, the log f0 values can then differ by 
~1 mM/s (from -8.25 mM/s  for 26 g/dl and -7.3 mM/s for 27 g/dl)  and the log B by 0.35 s-1(-
0.25s-1 for 26 g/dl and 0.12 for 27 g/dl). 
After mixing, two microliters of Hb are drawn from the container with a Drummond 
micropipette and, after wiping excess Hb which sticks to the outside of the pipette, the Hb is 
pipetted into the awaiting 5ml of CO buffer.  A spectrum is taken of each solution, and the three 
values are averaged to give a final Hb concentration.  The values of this are shown in table [4.1] 
for the samples used in the CO partial photolysis experiment. 
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Table [4.1]: The samples used in the CO partial experiment.  Concentration values before 
dilution with dithionite and phosphate buffer. *A,B,C,D; designates samples from different 
HbS preparations. Note that higher concentration measurements have a larger standard 
deviation in comparison to lower concentration measurements, see table [4.2]. 
Date Conc 
(g/dl)  1 
Conc 
(g/dl) 2 
Conc 
(g/dl) 3 
Conc Avg Conc 
Std 
% CO etc Hb 
Prep* 
9/30/2010 41.65 43.4 41.19 42.08 1.17 
95%CO   
5% Oxy 
A 
12/22/2010 41.3 41.86 44.7 42.62 1.82 
93% CO  
7% Met 
B 
2/9/2011 45.17 44.05 - 44.61 0.79 
88%CO  
12% Met 
B 
2/18/2011 34.36 38.5 - 36.43 2.93 
90% CO  
10% Met 
B 
4/29/2011 33.51 33.87 33.12 33.50 0.38 
90.4% CO 
9.6% Met 
C 
6/7/2011 37.96 35.67 - 36.82 1.62 
93% CO  
6.4% Met 
0.6% Oxy 
D 
 
 
 
Once the concentration of the initial Hb is known, the amount of buffer needed to dilute 
the Hb is calculated.  Sodium dithionite needs to be mixed with the buffer and hemoglobin 
solution so as to have a final concentration of 50 mM.  The high molarity of sodium dithionite 
ensures that any free O2 in the solution will be reduced.   The sodium dithionite is mixed with 
the CO HbS buffer, which is then used to dilute the HbS. To calculate the amount of sodium 
dithionite needed, consider the following:  suppose there is a hemoglobin stock solution of 
initial concentration 40 g/dl and it needs to be diluted to 26.6 g/dl.  A final sample volume of  
15 µl is desired because that is enough to make three samples each with 1.5 µl, and three 
concentration measurements of 2 µl each.  Therefore, 5 µl of buffer is mixed with 10 µl of the 40 
g/dl Hb.  The final concentration is calculated as: 
   
      
  
  (4.1) 
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Where     is the volume of the Hb to be added to the solution,    is the final total 
volume.  The calculation is restricted by the final solution having 50 mM of sodium dithionite.  
The buffer is taken from a stock solution of 2 ml of dithionite buffer mixture.  To calculate how 
many grams of dithionite to add to the 2 ml stock solution: 
                    
           
     
      
                           
     
 (4.2) 
 
where the mMoles are converted to Moles, 174 g/Mol is the molecular weight of dithionite, and 
      is the volume of the buffer that is added to the final solution, 5ul in this example. 
The correct amount of dithionite for this example is 0.0912 grams.  The dithionite is 
taken from a stock amount that is in a sealed container which is kept in an anaerobic chamber 
filled with nitrogen gas.  A small amount is weighted out on a precision mechanical scale and 
then sealed tightly in a small vial. The vial is then placed in the CO glove box where is mixed with 
the 2 ml of CO flushed buffer.  A measured amount of Hb is pipetted into a new vial and then 
mixed well with a few microliters of the sodium dithionite taken from the 2 ml stock solution 
(the amounts of HbS and buffer to be mixed are found from equation 4.1).  CO gas is allowed to 
flow into the vial, and then it is sealed and placed down for about two to three minutes.  This 
assures that the Hb reacts with the dithionite, loses all its oxygen, and binds with the CO gas in 
the buffer. 
Meanwhile, three tubes of 6 ml of CO buffer are prepared for concentration 
measurements, post dilution.  After waiting, the vial with the mixed Hb is opened, mixed again, 
and then 3 µl is pipetted into each awaiting concentration measurement.  The Hb vial is 
stoppered between each use to prevent drying.  The three tubes are then sealed with Parafilm® 
and immediately inverted and mixed.  The concentration measurements post mixing are shown 
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in table [4.2].  Next, three glass microscope slides and cover glass are wiped clean with a 
Kimwipe™, and 1.5 µl of the Hb mixture is placed onto the center of each slide.  They are then 
sealed air tight with wax melted on by a soldering iron. 
 
 
 
Table [4.2]: Dilution concentration measurements for the samples used in the CO partial 
photolysis experiment; with final average concentration and standard deviation of 
measurements.  Some samples have only two measurements due to small sample volume. 
 
 
 
4.2.2 Oxygen-carbon monoxide experiment sample preparation 
This experiment is often referred to as the “oxygen” experiment; however, these 
samples contain both oxygen and carbon monoxide.  Previously, samples were carefully 
prepared so as to not have any oxygen.  These however, were prepared by mixing oxy HbS with 
a small amount of CO HbS and diluting with deoxygenated buffer so as to minimize the free CO 
and oxygen in solution.  This method would create a sample with a stable ratio of CO and 
oxygen.  These samples would be tested much like the pure CO HbS samples because laser 
Date Conc 
(g/dl) 1 
Conc 
(g/dl) 2 
Conc 
(g/dl) 3 
Conc 
(g/dl) 4 
Avg Conc Std dev 
9/30/2010 28.7 28.89   28.8 0.13 
12/22/2010 28.3 27.56   27.9 0.52 
2/9/2011 26.89 26.25 26.77  26.64 0.34 
2/18/2011 37.38 36.3 35.56 36.07 36.33 0.77 
4/29/2011 26.78 26.44 26.37  26.5 0.22 
6/7/2011 26.53 26.77   26.65 0.17 
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photolysis causes HbS to release only the CO ligands.  This means that in an oxy HbS sample, 
only the CO is released while the oxygen population remains stable, allowing the effects of 
oxygen on HbS polymerization to be measured.  Oxygen samples were prepared in pH 7.05 
buffer, the pH that 50 mM of dithionite would change a CO HbS sample to.109  They are prepared 
similar to CO HbS samples; the HbS is mixed in the same container, as well as spectrum dilution 
measurements.  However that is where the similarities end.  For example, the HbS for oxygen 
experiments was never frozen, but was kept in a fridge and used fresh so as to minimize Met Hb 
formation.  Also, all the HbS used in the oxygen experiments came from a single Hb preparation 
and completely prepared in the cold fridge as to minimize met Hb. 
The HbS for oxygen experiments was divided into five vials which had their 
concentrations measured and then labeled.  Unlike in the CO experiments, the initial volume of 
HbS does not need to be precisely known before making a sample.  This is because the HbS will 
not be mixed with dithionite to obtain the final 50 mM amount.  One vial of HbS was exposed to 
CO in the CO glove box and was capped tightly and rotated for several hours.  The other vials 
were kept in an oxygen atmosphere.  To make a sample, first, a small amount of the CO HbS was 
placed into a vial (for example, 3 µl).  This vial then had any excess CO blown out by N2 gas.  This 
vial was then placed in a glove box with a nitrogen atmosphere.  To this vial was added a small 
amount of oxy HbS (5 µl for example) and deoxygenated buffer (buffer made by bubbling with 
N2) and was stirred with a microliter volume Drummond syringe.  The sample was then quickly 
made and sealed with wax.  Two dilution spectrum measurements would be made, one in 
Deoxygenated buffer and another in CO buffer.  The HbS could not be kept in the deoxygenated 
box for any extended period of time because it would quickly lose any oxygen it contained.  The 
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vial of oxy HbS also could not be kept in the box for this same reason, and would only be 
brought into the box right before the sample was made.  Different techniques were tried, and it 
was found that making a sample in the open atmosphere produced too much excess oxygen in 
the samples and they would not polymerize.  In table [4.3] are the values of the samples 
concentration when measured by dilution in CO and deoxy buffer.  The CO buffer measurement 
allows a spectral fit of just three parameters (CO, O2 and met HbS) and should give the more 
reliable value for the concentration.  The percentages of CO, met and oxy HbS are shown from 
the dilution spectrum measurement in deoxy buffer.   The percentages would not be accurate in 
the CO buffer due to the high binding rate of HbS for CO in comparison to oxygen. The final two 
columns in table [4.3] contain the percent met and oxy HbS as measured through a spectrum 
taken on the sample slide. 
The spectrum taken on an oxygen sample is much more complex than a CO sample.  For 
a CO sample, a baseline intensity is measured from 400 – 450 nm on a buffer sample, then the 
HbS sample intensity is measured.  However, for an oxygen sample, taking a spectrum with a 
mixture of CO, oxy and met HbS is not accurate.  This is in comparison to fitting a spectrum with 
deoxy, oxy and met HbS, whose peaks in the 400-450 range are further apart and more precisely 
resolved.   A deoxygenated spectrum is obtained by photolyzing the CO off of the HbS and then 
measuring the sample absorbance.  To obtain a deoxygenated spectrum, a larger area of the 
sample is exposed to the laser to be photolyzed (this is done by removing the mesh which splits 
the laser beam into micron sized holes).  A diaphragm is inserted in the laser path creating a 
specific photolyzed region (dark red circle in figure [4.2] left).  This produces an area of about 
170x170 pixels of photolysis.  Another diaphragm is inserted such that an area of 100x100 pixels 
(20x20 µm) of the photolyzed laser area is illuminated by the monochromator light (small dark 
93 
 
red circle in figure [4.2] on the right is the viewable area after the diaphragm is closed).  Then a 
square region of interest is chosen for measurement.  The square area is chosen in the center 
because the image will shift due to changing wavelengths.  Using a diaphragm allows only light 
from the photolyzed area to enter the camera and greatly decreases the scattered light from 
unphotolyzed areas of the sample (scattered light from an unphotolyzed region can produce a 
false signal of CO HbS in the spectrum).  While obtaining a deoxygenated spectrum, polymers 
may have formed during measurement.  To try to delay and decrease the amount of polymer 
formed, the sample is flashed with the laser for 0.2s and then the laser is turned off for 1 second 
before the next wavelength is taken.  Interesting to note, when polymers are formed the 
percent of oxygen decreases and the percent of met HbS increases slightly and deoxy HbS may 
increase slightly.  This occurred in sample #2 6/8/11 where polymers formed and 59% deoxy, 
29% met and 10% oxy HbS were measured, as opposed to 63% deoxy, 16% met and 20% oxy 
HbS in a spectrum without formed polymer.  This also occurred in sample #3 6/9/11 where 59% 
deoxy, 22% met, and 18% oxy HbS were measured when polymers formed, as opposed to: 59% 
deoxy, 16.8% met, and 23% oxy HbS without polymers. 
 
 
    
 
Figure [4.2]: Left: Dark circular area photolyzed is photolyzed by the laser.  Right: Diaphragm 
is placed over the lamp illuminating the sample and only a small circular area of the 
photolyzed region is viewable.  The small square shows the area imaged by the camera. 
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To analyze the spectrum data, several deoxygenated spectra were taken of each sample 
in the area of the experiment on the sample.  The error of each spectrum measurement is found 
from the standard deviation of each of these individually measured spectra.  To find the average 
spectra values, the optical densities of each spectrum at each wavelength were averaged 
together, and fit for the percentages of oxygen, met and deoxy HbS as well as the sample 
thickness.   The thickness is needed to compute the volume of the sample for the kinetics 
analysis.  In CO samples, sample thickness is easy to find, it is just the OD at 420 divided by the 
molar extinction coefficient (a known constant) and the concentration: 
        (4.3) 
 
However, when there are several components as there are in oxygen samples, the 
optical density becomes: 
        (                   )   (4.4) 
(                                 )    
 
where: 
                         (4.5) 
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Table [4.3]: The oxygen experiment samples parameters as given by dilution in CO and 
deoxygenated buffer; as well as their % oxygen and met as given by spectrum 
measurements taken on the sample stage. 
Date Sample Conc (g/dl) 
dilution 
(CO buff) 
Conc (g/dl) 
dilution 
(deoxy buff) 
Deoxy buff 
dilution 
component 
Conc std 
dev 
% Oxygen % Met 
6/7/2011 1 33.42 32.99 73% CO 
0.6% DO 
10% Oxy 
15% Met  
0.3 2.93% 10.53% 
6/8/2011 1 29.01 29.45 83% CO  
1.4% DO 
15% Met  
0.31 9.14% 9.66% 
6/8/2011 2 27.44 27.9 27% CO  
53% Oxy 
18% Met  
0.33 2.47% 25.94% 
6/9/2011 2 32.35 32.13 30.6% CO 
48% Oxy 
20.9% Met  
0.16 34.68% 21.5% 
6/9/2011 3 34 33.7 45% CO 
35% Oxy 
19% Met 
0.21 20.98% 20% 
6/10/2011 1 34.2 35.35 46% CO 
34% Oxy 
18.9% Met 
0.81 22.43% 16.46% 
6/10/2011 2.1 34.2 35.35 46% CO 
34% Oxy 
18.9% Met 
0.81 43.75% 17.09% 
6/10/2011 2.2 32.45 32.55 38.9% CO 
39% Oxy 
 21% Met  
.07 43.75% 17.09% 
6/11/2011 1 31.57 30.78 44% CO 
30% Oxy  
25.25% 
Met  
.56 22.5% 22.9% 
6/11/2011 2 35.9 34.3 47.3 % CO 
25.6% Oxy  
26.9% Met  
1.13 19% 22.7% 
6/11/2011 3 35.35 33.6 33% CO 
37 % Oxy  
29.6 % Met  
1.24 38.1% 21.64% 
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Table [4.4]: Comparing the spectrum data of CO and deoxygenated oxygen samples.  The % 
of met Hb in the CO spectrum was used as fixed percentage when fitting the deoxy 
spectrum. 
 CO Spectrum Data  Deoxy Spectrum Data  
Date Sample 
#  
Conc avg 
(g/dl) 
 % 
CO 
% 
MET 
 % 
OXY 
Thick 
(um) 
% CO % 
Met 
% O2 % 
Deoxy 
6/7/2011 1 33.21 89.5 10.53 0 4.87 0 10.53 2.93 86.54 
6/8/2011 1 29.23 83.66 9.66 6.67 3.32 0 9.66 9.14 81.2 
6/8/2011 2 30.34 43.16 25.94 30.9 7.38 6.3 25.94 2.47 65.29 
6/9/2011 2 32.24 43.06 21.5 35.44 4.11 0 21.5 34.68 55.8 
6/9/2011 3 33.85 54.18 20 25.82 5.29 0 20 20.9 59.02 
6/10/2011 1 34.78 59.51 16.46 24.02 3.57 8.86 16.46 22.43 52.25 
6/10/2011 2.1 32.5 42.45 17.09 40.45 0.891 2.06 17.09 43.75 37.1 
6/10/2011 2.2 32.5 42.45 17.09 40.45 3.46 2.06 17.09 43.75 37.1 
6/11/2011 1 31.18 52.18 22.9 24.96 4.261 0.822 22.9 22.5 53.78 
6/11/2011 2 35.1 53.17 22.7 24.12 2.58 7.5 22.7 19 50.8 
6/11/2011 3 34.475 38.7 27 34.32 2.76 3.01 21.61 38.1 37.3 
 
 
The CO spectra were analyzed to obtain the thickness of the samples which is used in the 
kinetics calculations.  The CO spectra were also analyzed for the percent of met Hb in the 
samples.  This percentage was forced to remain constant when the spectra were fit for the 
deoxygenated spectra.  The values found from the CO and deoxy spectra are compared in table 
[4.4].  Note how some of the spectra have a small amount of CO after fit in the deoxygenated 
spectra.  Increasing the laser power does not seem to affect this amount of CO; on the contrary, 
increasing the laser power too much burns the sample and causes more met HbS. 
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4.2.2.1  A note on met Hb 
Met Hb is Hb with the iron in the heme group in the ferric state, Fe3+ instead of Fe2+.  
Met Hb does not bind oxygen.  Typically 1-2% of a person’s Hb is met Hb.  Met Hb can be 
reduced with compounds such as sodium dithionite, which returns met Hb to the ferrous 2+ 
state, and physiologically by enzymes found in the red cell membranes.  Sodium dithionite also 
reduces oxygen which is why it was not used to reduce met Hb in the oxygen experiments 
conducted in this thesis.  The oxygen experiments data had about 20% met Hb as shown in table 
[4.3].  Reduction of the met Hb was attempted through several means.  The first method we 
attempted was to conduct the Hb chromatography from fresh blood which was never frozen 
and to do all the steps in the prep in the cold fridge when possible.  After all this, the HbS still 
had about 12% met Hb right after it was eluted from the column.  The final amount of met Hb 
would increase after the buffer was exchanged and the HbS was re-concentrated.   
Sodium dithionite reduces the amount of met HbS.  This is done by mixing the HbS in CO 
buffer and adding a small amount of dithionite.  For the duration of a one day experiment, the 
amount of met HbS in a sealed sample is nearly undetectable, but for the HbS in the oxygen 
experiment, such a method cannot be used.  This is because sodium dithionite will reduce all 
oxygen it comes in contact with, and to use a sufficient quantity to reduce the 20% met Hbs, will 
also remove all oxygen from the solution. Instead, in an attempt to reduce the amount of met 
HbS while retaining oxygen, a series of experiments were conducted where deoxygenated 
buffer was mixed with a small amount of sodium dithionite (~1mM) and HbS --but the amount 
of met HbS did not decrease.  After that result, other experiments were conducted where the 
amount of sodium dithionite was incremented; however, this actually caused the amount of 
met Hb to increase, even double in one case to 33%.  It was also found that if the sodium 
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dithionite-HbS mixture was allowed to re-oxygenate, the total amount of met HbS would be 
more than before adding sodium dithionite.  From these tests, we decided that reducing the 
met HbS was not possible by the usual means.  Another experiment was conducted where the 
HbS was passed through a chromatography column a second time, decreasing the met HbS by 2-
3% from 11%.  In conclusion, the immense effort expended was not deemed worth the small 
return in the reduction of met HbS.  
 
4.3 Apparatus 
The optical table had been originally designed by others110 for the purpose of measuring 
kinetics on completely deoxygenated HbS samples.  However, due to the necessity of measuring 
partial desaturation, laser intensity, and deoxygenated HbS spectrum, several components had 
to modified and improved.  The only elements kept unchanged from the original design were 
the position of the laser, lamp and sample stage. 
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Figure [4.3]: Schematic of the optical table used in the CO and oxygen experiments. 
 
 
 
Optical table equipment: 
1. 5W Spectra Physics 184 Argon 488nm laser used mainly in the 0.1W to 0.6W range. 
2. Laser shutter, controllable by computer and by a push button. 
3. Lens. 
4. Three reflective mirrors 
5. Metal mesh with 0.25um diameter holes spaced about 0.45um apart.   
6. Round graded neutral density filter used to decrease the laser intensity. 
7. Diaphragm used for laser alignment. 
8. Dichroic mirror.  Reflective for the laser light and transparent for the monochromator 
wavelengths. 
9. Back aperture, used for focusing the monochromator light on the sample. 
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10. Monochromator, receives light from the lamp, and outputs single wavelengths of light in 
the 400-450 nm range. SpectraPro-150, Acton research Corp.  0.150 meter focal length dual 
grating imaging monochromator/spectrograph. 
11.  150 W Xenon arc lamp.  The light is focused onto the monochromator slit by the lens. 
12.  Microscope lens (X amount of magnification needed) one before sample, one after.  
Before the sample, focuses the lamp and laser light onto sample.  After sample, collects the 
light from sample and sends it towards the eyepiece.  Both have adjustable foci and fstop 
(or aperture). 
13. Sample stage with temperature control. 
14. Notch filter, blocks specifically in the 488 nm range; used to block laser light in order to 
measure spectrum and desaturation (in diagram, the blue laser light incorrectly passes 
through the notch filter).  In a kinetics experiment, the notch filter is removed from the 
optical path and the laser light will be blocked by the dot in order to measure kinetics. 
15. Double bandpass colored glass filters (FGB245S), decreases transmittance in the 315-
445nm range.  Used to lower the intensity of the monochromator light. 
16. Projective eyepiece, similar to an eye piece in a stand up microscope, here it focuses the 
light for the two cameras to view instead of an eye. 
17. A thick glass slide with imprinted dots of varying sizes.  Used to block straight laser light 
so only scattered light passes through. 
18. Beam splitter box, sends some light to a live action video camera mounted on the optics 
table, and the rest to the CCD camera. 
19. CCD Photometrics Quantix 57 camera.  With a 535x512 imaging array and 13x13 µm 
pixels. 
20. Camera used to view sample live on TV screen. 
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21. Removable mirror, used to direct the laser light towards the laser power meter. 
22. Laser power meter. 
 
In reference to figure [4.3], the newly added elements to the optical table include the 
lenses directly after the laser, as well as an extra mirror (#4 with a star in figure [4.3] ).  The 
lenses were placed to expand the laser beams diameter slightly, so the gradient of laser light 
passing through the mesh would be more even.  The extra mirror was placed so as to prevent 
the laser light from being reflected at too drastic of an angle.  Since some lenses were removed 
from the optical path, the mesh was repositioned so that the laser light underwent a Fourier 
transform as it passed through the holes.  The Fourier transformed light is then refocused onto 
the sample via the back aperture microscope lens.  This is what causes the pattern of the mesh 
to appear on the sample. 
 
4.4 Data collection programs and devices 
4.4.1 Spectrum Data 
Spectrum data was collected using a code I wrote in IPLab based on a program originally 
written by Dr. Rotter.  It operated by incrementing the monochromator wavelength by 2 nm 
from 400 to 450 nm.  Images of 250 x 250 pixels were captured at 0.2 sec exposures.  The 
baseline images of the buffer sample were subtracted from these images and then they were 
averaged and the log10 was taken to find the optical density (OD): 
       (
 
  
)  (4.6) 
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Spectrum data was analyzed using a program based on code written by Dr. Rotter.  
The spectrum data collected was used to find the thickness of the sample at the local 
measured area.  The thickness is used to calculate the volume of photolyzed spots 
used in determining f0, the homogeneous nucleation rate. 
My modifications to the program included a new ability to average several spectra 
together and then fit the data.  I also added the capability of forcing a fixed percentage of met 
Hb while fitting the spectra data.  Figure [4.4] shows two CO-oxy-met HbS spectra averaged for 
sample 6/11/2011 #3.  The blue crosses are the optical density measured from the sample. 
 
 
 
Figure [4.4]: Spectrum of a CO-oxy sample.  Blue crosses are the raw data, the green line is 
the sum of the spectral components.  The red, purple and blue lines are the CO, oxy, and 
met HbS spectral components. 
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4.4.2 Light Scattering 
To measure light scattering, the optical table is setup as follows: Monochromator 
shutter is closed.  Laser light is passed through the mesh and illuminates the sample.  Laser light 
passes directly (straight) through the spots, and it will start to scatter as polymers grow.  The 
direct laser light is blocked by an imprinted spot on a glass slide.  The scattered light is refocused 
into the CCD camera, and the image will reappear as scattered light from multiple distinct spots.  
The CCD camera will take images in a continuous exposure setting.   
Kinetics data was collected using software created in Codewarrior by Dr. Aprelev and Dr. 
Zakharov.  The two programs used were for slow kinetics and fast kinetics.  The fast kinetic 
program operated by binning the pixels in the images collected by the camera, which allowed 
for faster gathering of images.  The image size was 500x500 pixels, with 1 pixel ~0.20 µm and a 
10x10 bin.  The slow kinetic program operated by capturing single images at predefined 
exposures and intervals.  This was usually 0.2 sec exposure at 0.2 sec intervals.  Fast kinetics is 
an experiment which took less than 90 seconds to be completed.  My improvements to the 
software included an automated collection capability, where the user can input how many data 
sets to collect, and how long to wait in between each set.  
 
 
4.5 Analyzing kinetics data 
4.5.1 Analyzing kinetics data – CO-oxygen  
The process of analyzing CO-oxygen data is discussed first as opposed to the partial CO HbS 
kinetic experiment.  The process for analyzing the partial CO kinetics data is a very similar 
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process to that described here, but with an added level of complexity that is discussed in the 
preceding sections.  Kinetics are obtained through the CCD camera on a 500x500 pixel area that 
has been binned to 10x10 bins, therefore the images obtained are 50x50 super pixels.  The 
transfer of collected camera data is limited, in that it can either obtain high spatial-resolution 
images with a low bin, or lower resolution images at a larger bin, at faster rate.  Low resolution 
at a high rate is necessary for measuring fast kinetics which could have tenth times less than a 
second.  Kinetics data is stored in an array of matrices, the rows in the matrix store each super 
pixel and the columns are that super pixel changing in time.  Areas of scattered light are located 
by summing all the intensity values in a column and plotting that matrix.  The image is shown in 
figure [4.5] as plotted via Matlab.  The islands in the figure show the areas where polymers grew 
and scattered light.  This matrix is used to identify the super pixels which are all part of the same 
scattered spot.  It is also used to identify and zero out scattered light from objects other than 
polymers, such as dust in or on the sample slide.   
 
 
Figure [4.5]: Scattered light summed matrix from the first data run, sample 6/10/2011 #1. 
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The raw data that is collected from each super pixel when plotted as function of time is 
shown in figure [4.6] left.  Notice in the beginning of the data set there are some data curves 
that start at a higher value (zoomed in, in figure [4.6] left).  These may be spots that have 
background scattered light and therefore have a baseline which will need to be zeroed out.  
There are so many curves because they are from each of the 50x50 super pixels.  However, the 
curves which are from the same spots in figure [4.5] will be combined into one curve.   Next, the 
data will then have any spots with maximum intensities less than 30% of the maximum 
scattered intensity removed  (this eliminates data curves that are at widely different intensities).  
Lastly, the baseline background of each curve is subtrated and the curves are renomalized to the 
maximum measured intensity value (figure [4.7]). 
 
 
 
 
Figure [4.6]: Left: raw intensity data versus image number, each curve is from a super pixel.  
Right: same data, zoomed in to show detail of curve beginning. 
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Figure [4.7]: Renormalized data for first data run, sample 6/10/11 #1. 
 
 
 
The beginning of each intensity progress curve is an exponential that is fit to find to find 
the polymer growth rate, B (equation 2.26).  The growth curves are solved for their tenth times, 
t10, i.e. the time it takes for the curve to reach one tenth of its maximum.  The tenth times are 
then plotted in a histogram.  The histogram is fit with Szabo’s function (equation 2.32) the tail of 
which is a decaying exponential, which will provide the nucleation growth rate, fo  (equation 
2.29). Figure [4.8] shows the histogram of tenth times, with the red curve as the fit to the data.  
Improvements in the kinetics code for this thesis work, allowed analysis of partially photolyzed 
samples which scattered different intensities of light in different areas of the sample. 
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Figure [4.8]: Tenth time distribution for data runs 1-9, sample 6/10/2011 #1. 
 
 
 
4.5.2 Analyzing kinetics data –measuring CO HbS desaturation 
Desaturation is the opposite of saturation in a sample.  Hb which has a gas molecule on 
each ligand is fully saturated.  Deoxygenated Hb is 100 % desaturated.  For HbS kinetics 
experiments, it is common to refer to the desaturation of a sample, since that is the physical 
state of upmost interest.  However, although desaturation will often be referred to in the data 
analysis, the final theory describing the behavior of the HbS will be in terms of saturation.  In 
this experiment the HbS is saturated with CO.  From the allosteric model, the number of HbS 
molecules with 0, 1, 2, 3 or 4 ligands can be quantified for a given partial pressure.  Once the 
number of each species is known, percent saturation becomes:  
             (  (  )       (  )      (  )       (  )  (  ))*100 (4.7) 
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Where X0, X1, etc. are the number of HbS molecules with 0 or 1 or 2, etc. ligands.  This percent 
saturation is relatable to the percent CO that is measured when a spectrum is taken of the 
sample.  Since the amounts of X0, X1, X2 and X3 can be solved for our system, the amounts of 
each population are known for any percent saturation of the HbS sample. 
To find the percent desaturation in partial CO photolysis experiments the relation 
between deoxy and CO HbS at 432 nm was used as well as the optical density (OD) of the 
sample at 420 nm.  The procedure is as follows, first a CO spectrum is taken of the sample.  The 
OD is found at 420 nm, which is where the CO spectrum peaks between 400 and 450 nm.  Next, 
the sample is illuminated at 432 nm.  Four images are taken, first the background with laser and 
lamp off (image 1).  Second, is with only the lamp on (image 2).  Third, the laser is turned on 
with the lamp already on and an image is taken (image 3).  Finally, the lamp is turned off and 
only the laser is on (image 4).  Each image is taken at a 0.2 second exposure.  Next, the intensity 
of CO HbS is found by subtracting image 1 from image 2 (removes stray light intensity) and the 
intensity of the Deoxy HbS is found by subtracting image 3 from image 4:   
                                                 (        ) 
                               (        )
                     (                 ) 
Dividing the intensity of CO HbS by Deoxy HbS at 432, and then taking the log is equivalent to 
finding the difference in their optical densities at 432.  However, to obtain an optical density, 
the intensity of lamp light through a buffer sample must be measured.  This would require 
removing the sample and then placing it back for each measurement.  To avoid moving the 
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sample after the experiment was begun, the mathematical relation was used.  Doing this will 
give a constant in each pixel of the image, K: 
                 
        
  
   (
       
       
)
        
    (4.8) 
 
Optical density (absorbance) is the negative of the log of the intensity divided by the 
background intensity (this ratio is also called transmittance), and is equal to the molar extinction 
coefficient multiplied by concentration and the sample path length: 
        (
 
  
)        (4.9) 
 
Expanding equation (4.8) using (4.9) gives: 
                       
           
    (4.10) 
 
where K is a known experimental quantity that comes from the measured images.  Letting the 
concentration of deoxy HbS be: 
           (4.11) 
where x is the fraction of deoxy HbS and Cco is the concentration of full CO sample.  Solving for x 
gives: 
  
                 
       
  (4.12) 
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and multiplying x by 100 will give the percent of deoxy or desaturation.  The values used for the 
molar extinction coefficients were: 111 
                                              
  
4.5.3 Analyzing CO desaturation 
The analysis of the CO data is similar to that of the oxygen experiment, except for the 
addition of analyzing partially photolyzed areas.  The laser’s center was off set so that an array 
of different intensities were created on a single sample.  The spots were analyzed for their 
intensities, which reached a maximum of ~2.8 kW/cm2.  The photolyzed areas were measured 
for their desaturation (or percent deoxygenation).  This was done by first thresholding the image 
to 4% desaturation, i.e. subtracting out the background noise in the 500x500 pixel image to 
leave “islands” of desaturation (figure [4.9], right).  Next, the locations of the desaturation areas 
are identified as well as the center of mass of each spot. The center area of each spot should 
receive the highest laser intensity as well be the most desaturated.  However, the program will 
sweep out to a radius of 6 pixels to find the maximum desaturation value in the center area.  
Then it will sweep out 8 pixels to find an average desaturation value for the immediate area.  
The program will then locate all the pixels in the photolysis spot which are within 10% of that 
averaged value (multiplying the new max by 0.9 and excluding values below this).  Since the 
laser power drops off exponentially excluding the lowest 90% decreases the area of photolysis 
(figure [4.9] left and figure [4.10]).  The final desaturation value for each spot was calculated by 
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averaging the remaining pixels within the original 10%.  These pixels along with the sample 
thickness are used to calculate the volume of the desaturation area. 
 
 
 
 
Figure [4.9]: Left: Desaturation image with threshold applied for noise.  Center of circles 
maximum is 0.3 (where 0.45 is maximum desaturation value).  Right: After subtracting out 
pixels outside of 10% maximum averaged desaturation. 
 
 
 
 
 
Figure [4.10]: Left: Zoomed in view of a single desaturation spot, black circle shows center of 
mass position.  Right: Same spot along the y=244 axis.  Horizontal line shows the cut off for 
10% of maximum average. 
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To conduct a full experiment, multiple desaturations images are taken as a defined 
amount of time passes, for different laser intensity values.  This was done to ensure that the 
percent desaturation remained constant until polymerization occurred.  Using different laser 
intensities also allowed for comparing of similar percentages of desaturation from different 
laser intensities.  Such comparisons are useful to show that the kinetics are related to the 
percent desaturation and not an artifact of heating of the sample.  Data tables [5.1] to [5.6] list 
laser power along with percent saturation, log fo and log B values.  It is clear from the data that 
there is no relation between a higher laser power setting and increased kinetics for the lowest 
saturations (full desaturation).  Figure [4.11] shows an example of percent desaturations as they 
evolve in time.  The laser power was set at 0.01 Watts and a filter was used to further decrease 
the laser intensity.   
 
 
 
 
Figure [4.11]: The percent of desaturation as a function of time for sample 2/18/2011, at 
0.01W laser power with an additional filter.  The delay time for this laser power was ~35 
seconds. 
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The desaturation image evolves over time, so a time is picked (usually the first or second 
image taken) and the volume and desaturation values for that image are used in data analysis.  
After the desaturation in each spot is located and tabulated, the image is scaled from 500x500 
to 50x50 which is the size of the kinetics image.  The desaturation spots are correlation to 
kinetics areas in a different program.  At this point, it is possible to pick a range of desaturation 
values, 40-45% for example, and to only pick the kinetics curves that come from that range of 
desaturation areas.  The kinetic progress curves from several experiments are all combined into 
a single data file which will then be analyzed like the oxygen data described in section 4.5.1. 
 
 
 
.  
Figure [4.12]: Left: 0.01W (with filter) data from sample 4/29/2011.  Green circles identify 
kinetics spots.  Yellow stars are desaturation spots in the range of 55-60%.  Areas where the 
circles and stars are within 2 pixels are a match between kinetics and desaturation.  Right: 
Same sample with 0.1W laser power.  The red areas are more numerous, meaning that 
more kinetic events occurred at the higher laser power.  The yellow stars indicate 70-75% 
desaturation. 
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4.5.4 CO diffusion in photolyzed CO HbS samples 
The measured quantity used to analyze data in this experiment, percent desaturation, 
arises from the combination of two effects.  The first is the CO released by photolysis, which 
depends on the intensity of the laser light, the concentration of the HbS, etc.  The relation 
between the amount of CO released and the fraction of deoxygenated Hb was quantified 
through a series of experiments conducted by Ferrone, et. al.112  The optical density of HbA was 
measured with a PMT while a laser at 514 nm photolyzed the HbA at different intensities.  The 
optical density is measured at times less than 10 ms, because times longer than 10 ms were 
shown to exhibit changes due to diffusion of CO out of the photolyzed area.  A relation was 
made between the fraction of deoxy Hb and the power density of the laser (kW/cm2).  The 
results of that experiment are shown in figure [4.13].  The fraction of deoxygenated Hb and its 
relation to the amount of CO is given by the following two equations: 
 
     
  [  ](    [  ])
      [  ](    [  ])
 
(    [  ])    (    [  ]) 
   (4.13) 
and 
[  ]        (4.14) 
 
where f is the fraction of deoxygenated Hb, [CO] is the free CO released by photolysis, KR and KT 
are binding constants which are the ratio of the association rates divided by the dissociation 
rates for Hb.  L0 is the equilibrium constant for none liganded Hb, γ is a factor which describes 
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and laser photolysis techniques. J. Mol. Biol. (183), 591-610. 
115 
 
the reduced solution volume accessible to the CO (which is 1.4 for 40g/dl) and c0 is the 
hemoglobin concentration in mM.  KR and KT are given by: 
    
           (4.15) 
    
           (4.16) 
With Tkon=2x10
5 M-1 s-1 and Rkon=1.2x10
7 M-1 s-1 and koff is defined as: 
     
         
     
  (4.17) 
 
where ε514 is the molar extinction coefficient for CO HbS (5,500 M
-1 cm-1), φ is the apparent 
photochemical yield and is less than one (0.47), I is the intensity of the laser, N is Avogadro’s 
number, and E is the energy of a photon at 514 nm. These values were used to calculate the 
solid red line in figure [4.14].  
However, the measured percent desaturation in this experiment also arises from a 
second effect, CO diffusion.   The rate of CO diffusion from a photolyzed region has also been 
studied by Ferrone, et. al. and a relation was made between the fraction of CO (F(t) in the 
equation) remaining at the center of the photolyzed spot and the radius of the spot as well as 
the time of measurement: 
 ( )       
    ⁄   (4.18) 
 
with D as the diffusion constant for CO and t is the time passed in seconds. 
Using the following values, a curve was produced which predicts the percent deoxy HbS 
versus the laser intensity (figure [4.14]).  The wavelength of the laser light was 488 nm, 
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therefore ε is 5400 M-1 cm-1,113 the concentration of the sample was 26.65 g/dl, the diffusion 
constant was extrapolated from given data values to be approximately 4.2x10-6 cm2/s114 (at this 
concentration) and the radius of the laser spot was 3.4 µm.  The blue line in figure [4.13] is the 
result of this calculation and it shows that the photolyzed areas had reached equilibrium with 
diffusion at the time they were measured.  Also, they had reached equilibrium with CO diffusion 
long before any kinetics occurred.  However, as the colored dotted points in figure [4.14] shows, 
the raw data measured in this experiment had maximum desaturation values around 87%.  This 
is due to diffracted light in the optical system which made the desaturation values appear lower 
than they should have been. 
 
 
 
 
Figure [4.13]: Effect of laser intensity on fractional saturation at a photolysis time of 2ms. 
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Figure [4.14]: Laser Intensity versus percent desaturation for sample 6/7/2011 and for the 
data in Ferrone et. al. 1985 paper. 
 
 
 
4.5.5 Diffracted monochromator light 
It was known that there was diffracted monochromator light in the optical system.  This 
stray light would cause images captured by the CCD camera to appear slightly brighter than they 
should have been.  Several control experiments were done to quantify the effect this would 
have on capturing images.  First, it was necessary to establish that full desaturation was reached 
through laser photolysis.  This was accomplished through a process similar to that described in 
section 4.2.2 and figure [4.2].  The mesh in front of the laser was removed, and a single large 
photolysis spot was created on a low concentration CO HbS sample.  A diaphragm which is at 
the position equivalent to the back aperture of a microscope and is in the path of the 
monochromator and not the laser (#9 in figure [4.3]) is closed until it overlaps some the laser 
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area.  Then a single wavelength desaturation measurement is conducted.  The results show two 
things, first that full desaturation is successfully reached, and second, that stray light causes the 
desaturation measurement to be off by a factor related to the amount of stray light.  The next 
experiments which were conducted were a series of measurements of how much the level of 
the diffracted light changed when a diaphragm was opened and closed on a CO HbS sample at 
432 nm.  It was found that the usual set up of using three filters and a notch filter for measuring 
desaturation actually minimized the effects of the diffracted light.  It was also found that the 
stray light was about 11% of the measured sample light intensity.  
To account for the stray light in the desaturation measurement, a calculation was done 
in Matlab to relate the measured desaturation to the actual desaturation.  First, a relation was 
made between the ideal (or actual) desaturation and the intensity of the laser light on a CO HbS 
area and a deoxy HbS area.   Consider equation (4.8), the definitions for the intensities in the 
text above it, and equation (4.10).  Equations (4.8) and (4.10) relate the intensity measured at 
the sample to the percent of desaturation.  Solving for the intensity of the photolyzed HbS areas 
gives: 
    
       
            
         (4.19) 
 
where Ioo is the intensity of a pixel with the lamp on and laser on (Deoxy HbS), Ioc is the intensity 
with the lamp on and laser closed (CO HbS), Ibg is the background image with the lamp and laser 
both off, and Ibglsr is the image with the lamp off and laser on.  K is as defined in (4.10) and is a 
function of the fraction of deoxygenated species and other known constants.  To solve for the 
actual desaturation, the following values were used: Ioc=500, Ibg= Ibglsr =120, ODco420=1.3.  These 
were the average values measured during the experiment.  Other values within reason (Ioc=600 
in steps of 100 up to 2000) were used and they changed the calculated relation minimally, by 1-
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3% which is within error.  Once the actual value for Ioo (lamp and laser on, deoxygenated HbS 
intensity) is known for each fractional desaturation, the same intensity values are then modified 
to account for the 11% light leak.  The intensities then become: 
                   (4.20) 
                      (4.21) 
 
where ICO is the CO HbS intensity with the background intensity subtracted and the fraction f of 
light leak, IDO is the intensity of the photolyzed area with the background intensity subtracted 
and the light leak added.   The measured fraction of desaturation becomes: 
                         
     
   
   
       
              
      
  (4.22) 
 
Figure [4.15] shows the relation of the measured fractional deoxy HbS to the actual fractional 
deoxy HbS.  The data points were fit with a second order polynomial: 
                            (4.23) 
and this was used to adjust the experimental desaturation percentages.  The desaturation error 
was recalculated by averaging the 10% maximum raw desaturation values in each experiment, 
and finding the standard deviation, which was 4.8.  This value was combined with the standard 
deviation from averaging the percent desaturation values by squaring the two error values, 
adding them and then taking the square root. 
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Figure [4.15]: Measured fractional deoxy HbS vs. actual fractional deoxy HbS. 
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Chapter 5: Analysis and theory of CO HbS partial photolysis 
 
5.1 Results of CO HbS partial photolysis experiment: raw data 
There were six different concentrations measured in the CO HbS partial photolysis 
experiment.  Each concentration was measured at a varying percent desaturation, which was 
controlled via the power output of the laser and through filters.  Shown in figures [5.1] to [5.6] 
are the percent desaturations versus time for the six different samples.  The figures are 
designated with the power level of the laser, as opposed to the intensity.  This is because the 
power level is a single setting, whereas the intensity varies in each spot producing the varied 
desaturations shown in figures [5.1] to [5.6].  The desaturation curves shown demonstrate that 
the samples had stable desaturation levels until polymerization occurs (polymerization is when 
the percent desaturation reaches 100 or above).  Greater than 100% is possible due to the 
polymers absorbing some of the monochromator's light.  In some figures, the desaturation level 
reaches 100% or more, but will then decrease back to a lower percent.  This is due to two 
factors; first, due to memory limitations of the imaging capturing software only four consecutive 
desaturation images could be measured at a time (recall that each final desaturation image is a 
product of four other images).  Second, because nucleation of HbS is stochastic, when the next 
set of desaturation images are taken, they might not have nucleated that time.  Figure [5.4] with 
sample #4, has such a scenario with the 0.06WF (F means there was an additional filter) 
desaturation measurement.  Due to the low level of photolysis, there was a longer delay in 
nucleus formation and the stochastic effects became more apparent. 
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Figure [5.1]: Desaturation of sample #1: 9/30/2010 28.3 g/dl. The x-axis is time in 
seconds and the y-axis is percent desaturation. 
 
 
 
 
Figure [5.2]: Desaturation of sample #2: 12/22/2010. 
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Figure [5.3]: Desaturation of sample #3 2/9/2011. 
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Figure [5.4]: Desaturation of sample #4 2/18/2011. 
 
 
Figure [5.5]: Desaturation of sample #5: 4/29/2011. 
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Figure [5.6]: Desaturation of sample #6 6/7/2011.  
 
 
 
After the kinetics curves are divided into their corresponding percent desaturation they 
are analyzed in groups which are incremented by 5%, for example, 70-75% and 65-70%.  The 
final value for the percent desaturation of a group of data curves is found by averaging the 
desaturation values in that group.  The error for the percent desaturation was discussed in 
section 4.3.2.  For easy of understanding the data, the desaturation was converted into 
saturation and presented as such in tables [5.1] to [5.6]. The error for log B was found by 
combining two different errors by taking the root of the sum of their squares.  The first error in 
log B arose from the standard deviation of the average B values obtained from the fit to the 
polymer growth curves.  The second source of error is the standard deviation of the different log 
B values which are measured in an experiment under all the same experimental conditions.  The 
standard deviation among the measured log B values is 0.15 s-1. The log fo errors are also a 
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combination of two errors.  First, as in the log B values, there is a standard deviation among 
experiments measured under all the same conditions.  Such an error may be a consequence of 
the stochastic behavior of the system.  The second source of error is a bit more complex 
however.  Recall that log fo is found by fitting function (2.32) to the histogram of tenth times 
(time it takes for a kinetics curve to reach 1/10th its maximum) the error is the uncertainty in the 
fit.  To find the error, a value in the histogram is varied until the chi squared value of the fit has 
increased by 1.115  The new distribution is fit for log fo again, and the difference between the 
new and old values gives the error.  Figure [5.7] shows three different tenth time distributions.  
The top graph in [5.7] is a histogram of the tenth times from 135 data curves with an average 
desaturation value of 77.4%.  The log fo value is -7.63 mM/s.  The fit of function (2.26) to the 
histogram is excellent, and a change in chi squared of 1 yields’ a small error of 0.08 mM/s.  The 
middle graph is a plot of tenth times from 44 curves, with an average desaturation of 81.28%.  
The peak of the distribution is between 3 and 5 seconds, but is not as well defined as the peak in 
the distribution on the top.  The middle distribution has a log fo of -7.73 mM/s and an error of 
0.28 mM/s.  The distribution on the bottom, has an even greater error as the shape and peak of 
the curve is more ambiguous.  It has only 30 data curves, and a log fo of -7.46 mM/s and error 
0.47 mM/s.  Although this data may appear to have a large error, it is still small when compared 
to the scale of log fo’s in this sample set; with the values varying between -9.28 mM/s to -7.34 
mM/s (63% and 86% desaturation). 
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Figure [5.7]: An example of three different tenth time distributions fit for log fo from sample 
2/9/2011. 
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5.1.1 A note on χ2 
 The chi-squared value listed in the data tables in the next section is the 
normalized χ2.   
χ2 is defined as:116 
   ∑
[ (  )   (  )]
 
  ( ) 
 
     (5.1) 
With N as the total number of measurements of quantity x.  There are n different 
possible xj and the data can be grouped into frequencies of observations, with the number in 
each bin as h(xj).  The probability of observing xj is P(xj) and the expected number of these 
observations is N*P(xj).  In the observed frequencies h(xj), each measurement xj has a standard 
deviation   ( ) associated with it. 
The normalized χ2 is: 
  
           (5.2) 
where   is the number of degrees of freedom and is also equal to the number of sample 
frequencies minus the number of parameters calculated from the data. 
The expected value of the reduced or normalized   
  is 1.  Values much larger or smaller 
than 1 come from large deviations from the assumed distribution and can imply poor 
measurements, incorrect assignment of uncertainties, or incorrect choice of probability 
function. 
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For the histograms in figure [5.7] the   
  was calculated by first calculating the variance 
of each binned frequency as: 
  ( )
  √
 (  )
    
   (5.3) 
next, the area of the histogram was normalized to 1, and a new function f was fit to the data, 
which is equivalent to the expected number of observations.  The equation is then divided by j 
the number of bins in the histogram, minus 3 (since the function fit to the data is constrained 
using two variables as well as by N). 
 
 
5.2 Results of CO HbS partial photolysis experiment: kinetics data 
There were six CO partial photolysis experiments successfully completed.  Table [5.1] to 
[5.6] shows the tabulated data from each experiment.  The first column is the power setting of 
the laser.  The power setting is not an indicator of the light intensity nor the photolysis level.  
The different power settings listed designate an experiment in which that group of data was 
collected together.  The second column shows a specified saturation range (where saturation is 
100- % desaturation) in which data curves where analyzed.  Next is the adjusted saturation, 
which accounts for the diffracted monochromator light.  The standard deviation of the 
saturation is a combination of the deviation from the averaged saturation values and the 
deviation from adjusting the values.  The tenth time given in the table is the minimum measured 
tenth time measured in that data set.  It should be noted however, that given more data, this 
value could become smaller.  The ‘data size’ lists the number of photolyzed progress curves 
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which were analyzed to obtain the data.  A large number of data should generate a better fit for 
log fo, although this might not be the case if the data has a large spread (as in slow kinetics).  
Finally as explained in section 5.1, the log fo error is found by changing the tenth time histogram 
so as to increase χ2 by 1. 
 
 
Table [5.1]: Sample #1 9/30/2010 28.8 g/dl analyzed data results. 
9/30/2010 Conc=28.8 g/dl  thickness=3.1um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s
-1
) 
log B 
std 
log f0 
(mM
-1
 s
-
1
) 
log f0 
error 
  
  Data 
size 
0.6W 30-25 26.85 16.55 6.29 1.35 0.54 0.09 -6.24 0.31 2.94 150 
0.6W 25-20 23.57 12.02 5.51 1.45 0.49 0.07 -6.4 0.36 2.42 68 
0.3W 30-25 28.97 19.45 5.61 1.83 0.53 0.1 -7.89 0.55 3.37 75 
0.3W 35-30 31.1 22.33 5.47 2.1 0.54 0.11 -7.49 0.68 0.44 29 
0.1W 45-40 42.24 37.03 5.69 4.94 0.27 0.13 -8 0.64 0.17 26 
 
 
 
Table [5.2]: Sample #2 12/22/2010 27.9 g/dl analyzed data results. 
12/22/2010 Conc=27.9 g/dl Thickness =4.46um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s
-1
) 
log B 
std 
log f0 
(mM
-1
 s
-1
) 
log f0 
error 
  
  Data 
size 
0.32W 20-15 15.8 1.07 5.21 1.63 0.43 0.1 -6.62 0.34 2.29 40 
0.32W 15-10 13.08 -2.84 5.9 1.63 0.44 0.08 -6.53 0.32 3.06 170 
0.02W 30-25 26.42 15.96 5.69 5.37 0.14 0.1 -8.36 0.48 0.59 55 
0.02W 25-20 22.96 11.18 5.84 3.95 0.18 0.11 -8.15 0.31 1.19 116 
0.02WF 35-30 31.12 22.36 5.63 8.17 0.14 0.12 -8.66 0.74 1.49 27 
0.02WF 30-25 27.388 17.29 6.47 5.18 0.25 0.11 -8.34 0.47 0.59 47 
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Table [5.3]: Sample #3 2/18/2011 26.64 g/dl analyzed results. 
2/9/2011 Conc=26.64 g/dl Thickness=3.3um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s
-1
) 
log 
B 
std 
log f0 
(mM
-1
 s
-1
) 
log f0 
error 
  
  Data 
size 
0.06WF 40-35 37.12 30.36 6.27 27.2 -0.36 0.19 -9.28 0.99 1.08 21 
0.06WF 35-30 31.85 23.34 5.82 19.7 -0.29 0.17 -9.26 0.60 1.18 44 
0.1W 25-20 21.83 9.60 6.3 4.45 -0.03 0.2 -7.82 0.32 0.69 122 
0.1W 30-25 28.63 18.98 5.83 4.47 -0.1 0.17 -8.00 0.80 0.49 22 
0.1W 20-15 18.29 4.62 5.82 4.72 -0.06 0.17 -7.78 0.35 2.19 72 
0.2W 20-15 18.57 5.01 5.98 4.05 0.13 0.28 -7.93 0.31 0.37 102 
0.2W 25-20 22.04 9.89 6.09 3.34 0.15 0.21 -7.76 0.32 0.33 96 
0.2W 30-25 27.27 17.13 6.54 4.13 0.09 0.2 -7.37 0.38 1.09 28 
0.3W 30-25 26.97 16.72 6.12 3.29 0.33 0.18 -7.6 0.49 0.32 44 
0.3W 25-20 23.08 11.34 6.22 3.36 0.27 0.18 -7.58 0.30 0.77 151 
0.3W 20-15 18.82 5.37 5.58 3.34 0.23 0.21 -7.42 0.82 0.67 24 
0.4W 20-15 18.72 5.23 5.71 2.8 0.34 0.19 -7.73 0.41 1.21 44 
0.4W 25-20 22.6 10.67 6.01 2.17 0.4 0.14 -7.63 0.31 1.62 135 
0.4W 30-25 27.56 17.52 6.4 2.34 0.43 0.14 -7.76 0.62 1.53 38 
0.5W 25-20 22.07 9.93 5.71 2.92 0.43 0.15 -7.19 1.54 1.29 22 
0.5W 20-15 17.3 3.21 5.96 2.63 0.43 0.13 -7.36 0.32 1.04 150 
0.5W 15-10 14.05 -1.44 5.07 2.83 0.37 0.16 -7.46 0.56 0.47 30 
0.6W 20-15 17.93 4.11 6.13 2.68 0.37 0.14 -7.42 0.30 1.25 118 
0.6W 25-20 21.79 9.54 6.26 2.61 0.42 0.14 -7.46 0.31 2.05 67 
0.6W 30-25 27.09 16.88 5.98 2.79 0.42 0.11 -7.38 0.62 0.65 22 
0.7W 25-20 22.24 10.17 6.38 2.5 0.47 0.2 -7.43 0.80 0.43 21 
0.7W 20-15 16.6 2.21 6.18 2.4 0.42 0.14 -7.37 0.33 0.51 106 
0.7W 15-10 13.92 -1.63 5.75 2.67 0.4 0.15 -7.34 0.36 0.78 64 
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Table [5.4]: Sample #4 2/18/2011 36.33 g/dl analyzed results. 
2/18/2011 Conc=36.33 g/dl Thickness =2.8um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s
-1
) 
log B 
std 
log f0 
(mM
-1
 s
-1
) 
log f0 
error 
  
  Data 
size 
0.01W 65-60 61.11 60.42 5.64 34.5 -0.16 0.16 -9.81 0.74 0.53 27 
0.2W 60-55 55.96 54.23 5.31 2.58 0.4234 0.261 -7.14 2.04 2.12 29 
0.2W 55-50 52.24 49.66 6.13 1.68 0.613 0.17 -7.065 0.32 2.97 161 
0.4W 55-50 50.69 47.74 5.35 0.96 0.86 0.14 -7.08 0.96 1.02 22 
0.4W 50-45 47.32 43.51 5.8 1.04 0.83 0.097 -6.79 0.34 1.52 97 
0.6W 50-45 47.07 43.20 6.2 0.67 0.84 0.13 -7.05 0.31 1.57 134 
0.6W 55-50 50.83 47.91 5.22 0.77 0.85 0.161 -7 0.79 0.36 23 
0.6W 45-40 43.54 38.70 6.03 0.69 0.91 0.12 -6.76 0.44 0.39 37 
 
 
 
Table [5.5]: Sample #5 4/29/2011 26.5 g/dl analyzed data results. 
4/29/2011 Conc=26.5 g/dl thickness=3.45 um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s
-1
) 
log B 
std 
log f0 
(mM
-1
 
s
-1
) 
log f0 
error 
  
  Data 
size 
p01WF 45-40 41.48 36.05 5.86 18.44 -0.103 0.103 -9.33 0.44 1.74 71 
0.01WF 40-35 38.12 31.67 5.28 18.56 -0.033 0.066 -9.124 0.62 0.815 38 
0.01W 30-25 26.75 16.41 5.84 3.93 0.155 0.13 -8.04 0.49 1.46 57 
0.01W 25-20 22.63 10.72 6.13 2.42 0.158 0.129 -7.81 0.30 3.08 266 
0.01W 20-15 19.24 5.96 5.53 4.035 0.11 0.19 -7.576 1.23 2.79 36 
0.1W 20-15 18.25 4.56 5.99 3.08 0.27 0.19 -7.58 0.30 1.72 213 
0.1W 25-20 21.57 9.24 5.9 3.12 0.226 0.178 -7.62 0.30 1.35 184 
0.3W 25-20 22.42 10.42 5.95 2.33 0.39 0.126 -7.19 0.30 0.86 111 
0.5W 25-20 21.95 9.77 5.63 2.08 0.572 0.11 -6.85 0.38 0.82 29 
0.5W 20-15 18.05 4.28 5.79 1.9 0.54 0.087 -7 0.51 0.65 35 
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Table [5.6]: Sample #6 6/7/2011 26.65 g.dl analyzed data results. 
6/7/2011 Conc=26.65 g/dl Thickness=3.8 um, T=25°C 
Laser 
power 
(Watts) 
Sat. 
range 
Sat. 
avg 
(%) 
Sat. 
adj. 
Sat. 
std 
t10min 
(sec) 
log B 
(s^-1) 
log B 
std 
log fo  
(mM^-
1 s^-1) 
log fo 
error 
  
  Data 
size 
0.04WF 40-35 37.03 30.24 5.87 19.96 -0.07 0.067 -8.92 0.91 1.02 19 
0.04WF 35-30 34.24 26.54 5.27 15.45 0.05 0.038 -8.86 0.64 1.711 34 
0.04W 30-25 27.64 17.63 5.92 3.48 0.25 0.27 -7.95 0.30 0.43 169 
0.1W 30-25 27.67 17.67 6.35 8.5 -0.2 0.11 -8.18 0.32 0.95 77 
0.1W 25-20 23.92 12.51 5.86 6.86 -0.2 0.14 -8.22 0.33 1.37 75 
0.2W 25-20 22.89 11.08 5.99 5.45 -0.026 0.11 -8.14 0.32 1.26 92 
0.2W 30-25 27.19 17.02 6.22 5.55 -0.11 0.121 -8.13 0.46 0.796 48 
0.5W 20-15 14.29 -1.09 6.08 1.98 0.64 0.093 -6.95 0.32 1.35 149 
0.5W 20-17 18.26 4.57 5.65 1.98 0.65 0.10 -6.94 0.36 1.37 89 
 
 
 
 For the lower concentrations: 26.65 g/dl and 26.64 g/dl between 0% to 30% saturation 
the log fo decreases by 0.066 mM/s and 0.046mM/s respectively per percent decrease in 
saturation. The log B for these two concentrations decreases by 0.022 s-1 and 0.018 s-1 for each 
percent decrease in saturation.  For the 36.33 g/dl sample, within the range of 38% to 60% 
saturation, the log fo decreases by 0.12 mM/s and the log B decreases by 0.05 s
-1. 
It is clear from the data tables [5.1] to [5.6], that the data does not extend from 0% 
saturation to 90% saturation.  The lower concentration samples have a range from about 0% to 
40% and the highist concentration 36.33 g/dl from 38% to 60% saturation.  The lower 
concentrations have tenth times around 1 to 2 seconds at 0% saturations.  Recall that tenth time 
is one tenth the time it takes for the scattered light from the polymers to reach its peak 
intensity.  The tenth times must be measured precisely because they are the values plotted in a 
histogram to solve for log fo.  The resolution of time measurement for kinetics on the CCD 
134 
 
camera is about 0.12 seconds and the shortest time that can be measured is 0.12 seconds.  This 
means that as the concentration of HbS increases, the tenth times will decrease.  For a 
concentration of 36.33 g/dl, the tenth times at 0% saturation will be faster than the measureing 
capabilities of the CCD camera.  That is why the lowest saturation measured for 36.33 g/dl was 
38.7%, with a tenth time of 0.69 seconds.  There are limitations on how high of a fractional 
saturation can be measured on a low concentrated sample.  The lower concentrations stop at 
about 37% and the longest tenth time measured was about 27 seconds.  Recall that 
homogeneous nucleation is a stochastic event, therefore, the nucleation event which happened 
at around 27 seconds is only the first.  The other nucleation events in such a sample would take 
several minutes to appear.  Measuring such a sample would take several hours and would yield 
a small amount of data.  In several hours, the sample may begin to dry and the sample may no 
longer produce reliable results.  For these reasons, lower concentrations are difficult to measure 
below 38% saturation. 
 
5.2.1 Modeling the CO HbS partial photolysis data 
 What is definitively measured here is the behavior of deoxy HbS polymerization in the 
presence of a mixed species of liganded CO HbS.  In simplified terms, such an experiment can be 
modeled as having a polymerizing population and a non-polymerizing population.  In fact, the 
general model for such a system has already been presented by Rotter et. al. in 2005.117 
However, the conditions presented here are unique in that the fraction of non-polymerizing HbS 
is related to a ligand distribution and not a mixture of HbS species, as was presented in Rotter’s 
                                                          
117
 Rotter, Maria. Et. al. (2005). Molecular crowding limits the role of fetal hemoglobin in therapy for sickle 
cell disease. Biophysical Journal. (347). 1015-1023. 
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work.  Modeling the ligand distribution of HbS is complicated because HbS has four ligands, and 
each liganded state has a probability of being in an R or T configuration (whereas the R 
configuration cannot polymerize, and the T-state has a probability of doing so which depends on 
the number of ligands which the CO HbS has), each fractional saturation of CO HbS has a unique 
distribution of ligands which are derived through the allosteric model described in section 2.3.  
In addition to this, photolyzing HbS changes its allosteric parameters in comparison to a partial 
pressure measurement, which must also be accounted for.  The allosteric parameters used in 
modeling the data were: Lo=6x104, KR=160 and c=0.06.
118  The Lo and c parameters produced 
the graph in figure [5.8] where the circles show the different fractional species of T which were 
used to fit the data at the different saturations listed in column 4 of tables [5.1] to [5.6]. 
 
 
 
                                                          
118
 Ferrone, F. A. (1985). Kinetics of sickle hemoglobin polymerization I.  Studies using temperature-jump 
and laser photolysis techniques. J. Mol. Biol. (183), 591-610. 
136 
 
 
Figure [5.8]: Fraction of T0,T1, T2, T3 and T4 species versus fractional saturation for the 
allosteric parameters Lo=6x104, KR=160, and c=0.06. Each circle is a fractional saturation at 
which an experiment was performed. 
 
 
 
 The species of T0, T1, T2, T3 and T4 in the CO HbS experiment have been solved through 
the allosteric model, using the parameters for Hb under photolysis.  In chapter 3, section 3.2, it 
was discussed that Sunshine et. al. found oxygen had a copolymerizing probability of 0.37 for 
the T1 state, (0.37)2 for T2, etc.  To include this in the model, the number of T1, T2 etc. species 
would be multiplied by this factor, and the number of species left are added together to find the 
fraction of polymerizable species. For example, figure [5.9] shows the total number of T states 
(T0 +T1+T2+T3+T4) in blue plotted against fractional saturation (notice the total number of T-
states decreases as fractional saturation increases, this is because the Hb is switching into the R-
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state configuration).  The green line in figure [5.9] shows the model for: T0+0.37*T1+ 
(0.372)*T2+ (0.373)*T3+ (0.374)*T4 with the sum as the new fraction of polymerizable species.  
The circles in figure [5.9] are fractional saturations at which data was collected. 
 
 
 
 
Figure [5.9]: The sum of T states for two different copolymerization models.  Blue: T0 
+T1+T2+T3+T4.  Green: T0+0.37*T1+ (0.372)*T2+ (0.373)*T3+ (0.374)*T4. Circles show 
fractional saturations at which data was collected. 
 
 
  
In relating the fraction of non-polymerizing species to the double nucleation theory 
defined in chapter 2, sections 1 and 2, it is found that there four main changes.  First is the 
supersaturation, S (equation 2.24) which is the ratio of the activity of Hb at that concentration 
to the activity of the Hb at equilibrium.  The super saturation becomes: 
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             (5.4) 
where cd is the concentration of deoxy HbS (or in our case the fraction of polymerizing species), 
γs cs are the activity and the concentration at solubility, and γT is the activity of the total HbS, 
including the non-polymerizing fraction.  Since S has changed, the nucleus size will in turn be 
modified: 
   
 
   
    (5.5) 
therefore, becoming a larger value with the addition of a non-polymerizing species. 
 The elongation rate of a polymer decreases as well becoming: 
 ( )    (        ) (5.6) 
where k+ is the monomer addition rate. The addition of a fractional non-polymerizing species 
requires a larger nucleus size, and simultaneously decreases the polymer growth rates.  Contrast 
this to instead decreasing the concentration of the monomers, c.  Doing such would decrease 
the activity coefficient, γ, which depends on concentration as:  
       (   )   (5.7) 
and φ is 
      (5.8) 
where V is the volume of the Hb molecule and c is the concentration.  A decrease in both γ and c 
would clearly have a greater impact than decreasing c alone.  In comparison to just decreasing 
the monomer concentration, a non-polymerizing species crowds the solution, thereby slightly 
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counteracting the decrease in kinetics with a small increase.  Such an effect is modeled 
effectively by the change in c and not γ in the nucleation theory. 
 
5.3 Comparison of data to model 
The CO HbS data was fit to the model proposed in chapter 2 section 2 by Sunshine et. al.  
The model is a two-state allosteric model which stipulates that only HbS molecules in the T-state 
can polymerize; polymerized HbS can still bind oxygen  and have the same oxygen affinity as 
solution phase T-state molecules; and the binding of oxygen is not influenced by the ligation 
state of other HbS nearby in the polymer.  From this model it was deduced that HbS in the 
polymer have a 0.37 probability to have a bound T1.  Likewise, there is a 0.372 probability for T2, 
and so forth for T3 and T4.  Letting a equal 0.37, the co-polymerization probability for T1, the 
fraction of polymerizable species becomes: 
               
                (5.9) 
This model was successful in describing the gelation of HbS in the presence of oxygen, which is 
the polymer binding curve in the Hill plot in figure [3.5]. This model was also successful in 
describing the polymer growth rate, J, in an experiment on 25.5 g/dl HbS at 25.5 °C with 49% CO 
HbS at pH 7.35, as well as in other experiments with a pH of 6.85.119  When this model was 
applied to the data collected for the nucleation rates of the CO HbS experiment, it was found to 
only have some correlation to the log fo and log B of the 36.33 g/dl sample.  The other lower 
concentrations had nucleation rates which were faster than the theory predicted (figure [5.10]).  
The goodness of fit    is given in table [5.7] for the sum of the points of each concentration.  
                                                          
119
 Aprelev, A. et. al. (2011). The growth of sickle hemoglobin polymers. Biophy. J. (101) 885-891. 
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The HbS used in these experiments had values of log fo and log B for 0% saturation which were 
faster than the original nucleation theory predicted.  The difference at 0% cannot be caused by 
the partial ligand populations, but it can however, be modeled in the original theory by a change 
in cs, the solubility concentration.  Figure [5.11] shows the data plotted with cs modified as 
stated in table [5.8].  The value for the solubility concentration is usually 17.6 g/dl at 25°C.  In 
addition to adjusted cs, a parameter in the theory of log B is in turn slightly adjusted to 
compensate.  The term is: ln φ, which was introduced in chapter 2 as the proportionality of 
nucleation sites per polymer.  This value is increased by 3.5 in the analysis of each of the 
samples.    Notice table [5.8] the three samples from the same preparation of HbS, B, have 
similar adjusted values.  In fact, two of them have the same adjustment.  Based on the dates 
these samples were made, it appears there may be some relation between the age of the HbS 
and the amount that cs is adjusted. 
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Figure [5.10]: The model of a=0.37 without adjusted cs.  Top 6 plots show log fo data fit for 
the six samples with a, the copolymerization constant, with a value of 0.37.  Bottom 6 plots 
are the log B’s. 
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Figure [5.11]: Top 6 graphs are log fo with modified cs. Bottom 6 are log B with modified cs.  
All data is fit for a=0.37. 
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Table [5.7] The    values of the CO partial data fit to theory. 
        CO Partial Experiment  
Sample Conc (g/dl)     log fo    log B 
9/30/2010 28.8 27 39 
12/22/2010 27.9 16 33 
2/9/2011 26.64 152 112 
2/18/2011 36.33 10.7 11 
4/29/2011 26.5 195 160 
6/7/2011 26.65 71 103 
 
 
 
Table [5.8] The values used for the adjustment of cs in analyzing the kinetics data. 
HbS Prep Date Concentration 
(g/dl) 
cs modifier 
(g/dl) 
A 9/30/2010 28.8 -2.45 
B 12/22/2010 27.9 -1.03 
B 2/9/2011 26.64 -1.61 
B 2/18/2011 36.33 -1.61 
C 4/29/2011 26.5 -2.84 
D 6/7/2011 26.65 -2.26 
 
 
 
 
 The oxy-CO HbS data was then plotted with the CO HbS data in a correlation plot (figure 
[5.12]).  A correlation plot is a plot where the values measured by the experiment are plotted as 
the x-axis and the values predicted by the theory are plotted on the y-aixs.  A perfect fit 
between theory and experiment would place a point on the diagonal black line in the plot.  The 
goodness of fit    for each concentration is given in table [5.10]. The oxy-CO HbS samples also 
had a percentage of met HbS which was incorporated into the fraction of non-polymerizable 
species (the same method was used in the Sunshine et. al.  oxygen experiment described in 
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chapter 3).  The oxy-CO HbS data also had its cs adjusted by -1.03 g/dl and ln φ by 3.5.  The 
model shows a greater agreement with the faster nucleation rates in both graphs.  For the lower 
values of log fo and log B, the theory predicts a slower homogenous and heterogeneous 
nucleation rate than was actually measured.  Such a result signifies that a copolymerization 
probability of 0.37 may be too generalized to describe all the data.  The nucleus size increases as 
the fraction of non polymerizable species increases.  It is possible that a larger nucleus could 
allow a more lenient arrangement of liganded monomers, thereby causing a faster kinetic rate 
as opposed to the slower ones predicted by the theory.  However, such an observation cannot 
be clearly discerned from just these measurements alone.   A future direction with this work 
would be a study of the larger size HbS nuclei in the presence of liganded HbS. 
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Figure [5.12]: Top: Correlation plot of CO HbS and oxy-CO HbS data for log fo.  Bottom: 
Correlation plot of CO HbS and oxy-CO HbS data for log B. 
 
 
The data from the oxy-CO HbS experiment which is plotted in figure [5.12] is listed in table 
[5.9].  Std is standard deviation, and t10 is the minimum measured tenth time for that 
sample.  The error for log fo and B is the same as described for the CO HbS experiment. 
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Table [5.9] The data from the oxy-CO HbS experiment. 
Date Conc 
(g/dl) 
Std 
Conc 
% Oxy % Met Log fo Log fo 
error 
Log B Std 
logB 
 t10 
(secs) 
6/7/2011 33.2 0.30 2.93 10.53 -6.08 0.38 1.34 0.19 0.29 
6/8/2011 29.2 0.31 9.14 9.66 -8.13 0.30 0.36 0.21 2.69 
6/9/2011 32.2 0.16 34.68 21.5 -8.82 0.45 -0.08 0.24 9.21 
6/9/2011 33.85 0.21 20.98 20 -7.9 0.33 0.33 0.21 3.3 
6/10/2011 34.78 0.81 22.43 16.46 -6.47 0.31 1.56 0.18 0.26 
6/10/2011 32.5 0.07 43.75 17.09 -7.67 0.33 0.69 0.22 1.2 
6/10/2011 32.5 0.07 43.75 17.09 -7.07 0.32 0.69 0.22 1.52 
6/11/2011 31.18 0.56 22.5 22.9 -7.44 0.31 1.26 0.23 0.49 
6/11/2011 35.1 1.13 19 22.7 -6.57 0.30 1.13 0.21 0.5 
6/11/2011 34.5 1.24 38.1 21.64 -7.57 0.30 0.72 0.21 1.01 
 
 
 
Table [5.10]    for partial oxygen experiment. 
             Experiment 
Conc (g/dl) % Oxy    log fo    log B 
33.2 2.93 28.4 5.5 
29.23 9.14 17.5 2.3 
32.24 34.68 9.4 0.8 
33.85 20.98 24.6 14 
34.77 22.43 8.3 1.1 
32.5 43.75 115 35.6 
32.5 43.75 169 35.6 
31.2 22.5 21.7 25.8 
35.1 19 9.9 1.3 
34.5 38.1 20.3 4.9 
 
 
The homogenous nucleation data presented here can in turn be related to the delay 
times measured by Hofrichter, and discussed in chapter 3. Figure [5.13] shows the log10 of the 
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tenth times (in minutes) of two samples measured by Hofrichter (one at 20°C the other at 35°C).  
The delay time can be calculated from the theory by solving for the time at which the 
concentration of monomers in polymers, Δ, is one tenth of its maximum value.  The equation for 
Δ is: 
  
 
 
(   (  )   )  (5.10) 
and the maximum of delta occurs when: 
  
 
 
(     )   (5.11) 
One tenth this will give the delay time, or also called, the tenth time: 
 
  
 
 
  
(     )  
 
 
(   (    )   )  (5.12) 
    
  (
 
  
(     ) 
 
      
  )
 
   (5.13) 
where          .  The values for        and   can all be solved using the nucleation theory 
which is modified to account for the fraction of non-polymerizing.  The fraction of non-
polymerizing is calculated from the copolymerization model using a=0.37 and the allosteric 
parameters for CO HbS, c=0.01 and Lo=6e4. 
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Figure [5.13]: Delay times measured by Hofrichter on gelled CO HbS samples, compared to 
the theory for a=0.37 copolymerization probability. 
  
  
 
When considering the data and theory curves in figure [5.13], it is clear that at 0% 
saturation the theory and the data do not match.  To appropriately align the theory with the 0% 
saturation data, the theory requires an increase in cs of 0.64 g/dl.  Such adjustments to the cs 
value demonstrate that there is a slight difference between the HbS used in different 
experiments.  The cause of such inconsistencies has been considered, but the exact mechanism 
has not yet been identified.  One theory put forth, has been that the amount of free heme in the 
HbS solution changes the kinetics.   A free heme is the non-protein component of the HbS, and 
the removal of the heme will decrease the polymerization rates, while the addition will increase 
it.120  When HbS becomes met HbS it may release the heme, and this heme could potentially be 
                                                          
120
 Uzunova, V. V. et. al. (2010). Free heme and polymerization of sickle cell hemoglobin. Bio. J. (99). 1976-
1985. 
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removed or even concentrated through the processes of purifying HbS.   Another possible 
explanation of the discrepancy could be the change in pH brought about through the reduction 
of met HbS with sodium dithionite.  Differing amounts of oxygen and met HbS could cause the 
reaction of the solution with sodium dithionite to have slightly different final pH values.  Finally, 
there have also been some anecdotal observations in the Ferrone research group, that fresh and 
older samples had slightly varying kinetics, with older samples being faster.  Such differences 
may be due to the sodium dithionite interacting with the HbS for long periods of time, but no 
rigorous study of this has been done on the samples used in these experiments.  
 
 
5.4 Relating the model to previous experiments 
The two experiments described in chapter 3 were conducted on polymers which were 
already gelled.  The results showed here come from a laser photolysis experiment.  Laser 
photolysis allows the measurement of the homogenous and heterogeneous nucleation rates, 
whereas gelled experiments can be used to study solubility and polymer composition.  
Fundamentally these are very different experiments, but ideally the results should agree once 
the difference in allosteric conditions is accounted for.  From the experiment conducted by 
Sunshine et. al. it was concluded that the relative affinity of the polymer for oxygen and carbon 
monoxide must be the same at the same temperature.  The oxy-CO HbS data presented here 
has a large dispersion; however, it generally lies within the range of dispersion for the CO HbS 
data.  This further demonstrates that the polymer and nucleus’s tolerance for ligands is the 
same regardless of whether the ligand is CO or O2. 
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5.5 Therapeutic implications of the data 
Currently it is now possible to model the delay time for polymerization of intracellular 
HbS at 50% saturation.  The allosteric parameters for oxy HbS are defined, and now the behavior 
of oxy HbS polymerization is defined.  Combining these two models, it is possible to calculate 
the time it takes for intracellular HbS to polymerize at 50% saturation.  The value of 50% is used 
because this is the amount of oxygen most cells will release on average during their circulation.   
The concentration for intracellular HbS is in the range of 29 g/dl to values as high as 35 g/dl.  A 
50% saturated oxy HbS solution with concentration 32 g/dl and at 37.5°C will have a delay time 
of about 37 seconds, and will reach solubility in about 6 minutes.  A 34 g/dl solution at 37.5°C 
will have a delay time of 6 seconds, and will reach solubility in one minute (see figure [5.14]).  
These times however, are for a pH of 7.05.  At the physiological pH of 7.35, these times will be 
slightly faster.  The transit time of red blood cells through the capillary is 1 second or less.121  
According to the data in figure [5.14], one second is approximately the delay time for 
concentrations of 36 g/dl.  
                                                          
121
 Kaul, D. K. et. al. (2004). In vivo studies of sickle red blood cells. Microcirculation. (11). 153-65. 
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Figure [5.14]: Delay times of 50% saturated oxy HbS at 37.5°C. 
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Chapter 6:  Summary 
 
 
6.1 Review 
This work was the first to measure the nucleation kinetics of partially saturated CO and oxygen 
HbS samples.  Such an experiment was not done previously due to the complex nature of the 
measurement.  Measuring nucleation, which is a stochastic event, requires a large amount of 
data to be collected.  The creation of partial saturation areas requires precise control of the 
laser intensity, capability to measure the amount of saturation through both programs and 
individualized optics, and lastly, extensive analysis must be conducted to extract the correct 
amount of partial saturation and relate it to the nucleation kinetics. Here we have provided an 
experimental procedure to measure partial saturations using laser photolysis.  There is also now 
a new method of preparing CO-oxygen samples to be used in laser photolysis experiments.  This 
is also the first time that the allosteric model and ligand populations have been incorporated 
into the nucleation theory.   
There are two major findings of this thesis.  First, the copolymerization of liganded Hb is 
a reasonable approximation for describing the behavior of homogeneous and heterogeneous 
nucleation.  Second, the nucleation rates for fractional saturation with CO and O2 are similar, 
implying that the kinetic data with CO as a ligand is a good surrogate for data with the 
physiological ligand of O2.  The amount of noise in the data makes it difficult to definitively say 
whether another model would be a better fit.  Now that a methodology for measuring partial 
CO and oxygen HbS saturations exists, perhaps future experiments can improve the precision of 
the measurement. 
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6.2 Directions of future work 
These experiments show that equilibrium polymer behavior and nucleation behavior is 
similar (considering the error involved in the nucleation measurements), in the presence of 
liganded HbS.  However, there are two discrepancies which warrant further study in this field.  
The first, is the deviation of the slower kinetics from the a=0.37 model.  It appears that for larger 
nuclei sizes there may be a higher copolymerization probability. This  is similar to stating that 
lower concentrations (around 26 g/dl) appear to fit better to a model with a higher co 
polymerization probability than 0.37 (as compared to samples at the same fractional saturation 
but with a higher concentration).  A more extensive study on nuclei sizes of partially liganded 
HbS could yield information regarding a more forgiving conformation of larger nuclei with 
partially liganded HbS.  The second discrepancy which should be further studied, is the 
adjustment of the cs to appropriately describe 0% saturated HbS.  Could such a discrepancy be 
due to the free hemes?  Although there has been some study done on this issue, this question 
has still not been definitively answered and warrants future study. 
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